<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66768</article-id><article-id pub-id-type="doi">10.7554/eLife.66768</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>miR-1 coordinately regulates lysosomal v-ATPase and biogenesis to impact proteotoxicity and muscle function during aging</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-223198"><name><surname>Schiffer</surname><given-names>Isabelle</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-223199"><name><surname>Gerisch</surname><given-names>Birgit</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-223200"><name><surname>Kawamura</surname><given-names>Kazuto</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0376-7739</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223201"><name><surname>Laboy</surname><given-names>Raymond</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0375-1550</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223202"><name><surname>Hewitt</surname><given-names>Jennifer</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8798-1811</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-162967"><name><surname>Denzel</surname><given-names>Martin Sebastian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5691-3349</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81792"><name><surname>Mori</surname><given-names>Marcelo A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223203"><name><surname>Vanapalli</surname><given-names>Siva</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223204"><name><surname>Shen</surname><given-names>Yidong</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-223205"><name><surname>Symmons</surname><given-names>Orsolya</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2435-4236</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3859"><name><surname>Antebi</surname><given-names>Adam</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7241-3029</contrib-id><email>antebi@age.mpg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Max Planck Institute for Biology of Ageing</institution><addr-line><named-content content-type="city">Cologne</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution>Department of Chemical Engineering, Texas Tech University</institution><addr-line><named-content content-type="city">Lubbock</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne</institution><addr-line><named-content content-type="city">Cologne</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution>Laboratory of Aging Biology, Department of Biochemistry and Tissue Biology, University of Campinas (UNICAMP)</institution><addr-line><named-content content-type="city">Campinas</named-content></addr-line><country>Brazil</country></aff><aff id="aff5"><label>5</label><institution>Experimental Medicine Research Cluster (EMRC), University of Campinas (UNICAMP)</institution><addr-line><named-content content-type="city">Campinas</named-content></addr-line><country>Brazil</country></aff><aff id="aff6"><label>6</label><institution>Obesity and Comorbidities Research Center (OCRC), University of Campinas (UNICAMP)</institution><addr-line><named-content content-type="city">Campinas</named-content></addr-line><country>Brazil</country></aff><aff id="aff7"><label>7</label><institution>State Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences</institution><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Leiser</surname><given-names>Scott F</given-names></name><role>Reviewing Editor</role><aff><institution>University of Michigan</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kaeberlein</surname><given-names>Matt</given-names></name><role>Senior Editor</role><aff><institution>University of Washington</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>27</day><month>07</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e66768</elocation-id><history><date date-type="received" iso-8601-date="2021-01-22"><day>22</day><month>01</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-07-03"><day>03</day><month>07</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Schiffer et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Schiffer et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66768-v1.pdf"/><abstract><p>Muscle function relies on the precise architecture of dynamic contractile elements, which must be fine-tuned to maintain motility throughout life. Muscle is also plastic, and remodeled in response to stress, growth, neural and metabolic inputs. The conserved muscle-enriched microRNA, miR-1, regulates distinct aspects of muscle development, but whether it plays a role during aging is unknown. Here we investigated <italic>Caenorhabditis elegans</italic> miR-1 in muscle function in response to proteostatic stress. <italic>mir-1</italic> deletion improved mid-life muscle motility, pharyngeal pumping, and organismal longevity upon polyQ35 proteotoxic challenge. We identified multiple vacuolar ATPase subunits as subject to miR-1 control, and the regulatory subunit <italic>vha-13</italic>/ATP6V1A as a direct target downregulated via its 3′UTR to mediate miR-1 physiology. miR-1 further regulates nuclear localization of lysosomal biogenesis factor HLH-30/TFEB and lysosomal acidification. Our studies reveal that miR-1 coordinately regulates lysosomal v-ATPase and biogenesis to impact muscle function and health during aging.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>miR-1</kwd><kwd>lysosomal v-ATPase</kwd><kwd>vha-13</kwd><kwd>polyglutamine</kwd><kwd>proteostasis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002347</institution-id><institution>Bundesministerium für Bildung und Forschung</institution></institution-wrap></funding-source><award-id>0315893A</award-id><principal-award-recipient><name><surname>Antebi</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001655</institution-id><institution>Deutscher Akademischer Austauschdienst</institution></institution-wrap></funding-source><award-id>57518567</award-id><principal-award-recipient><name><surname>Antebi</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004189</institution-id><institution>Max-Planck-Gesellschaft</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Antebi</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001807</institution-id><institution>Fundação de Amparo à Pesquisa do Estado de São Paulo</institution></institution-wrap></funding-source><award-id>2019/25958-9</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Marcelo A</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002322</institution-id><institution>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</institution></institution-wrap></funding-source><award-id>88881.143924/2017-01</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Marcelo A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Coordinate control of lysosomal v-ATPase subunits and biogenesis factor TFEB by miR-1 identifies a key regulatory axis with strong links to age-related proteotoxic disease.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Aging is the major cause of progressive decline in all organ systems throughout the body. This is particularly evident in the musculature and often manifests as sarcopenia, the loss of muscle mass and strength. In fact, muscle frailty is a hallmark of tissue aging seen in species as diverse as worms, flies, mice, and humans (<xref ref-type="bibr" rid="bib12">Cruz-Jentoft et al., 2010</xref>; <xref ref-type="bibr" rid="bib13">Demontis et al., 2013</xref>; <xref ref-type="bibr" rid="bib23">Herndon et al., 2002</xref>; <xref ref-type="bibr" rid="bib34">Martinez et al., 2007</xref>; <xref ref-type="bibr" rid="bib36">Miller et al., 2008</xref>; <xref ref-type="bibr" rid="bib40">Nair, 2005</xref>). At the molecular level, frailty is often accompanied by a decline in muscle structure and function, as well as alterations in muscle proteostasis and metabolism. Nevertheless, muscle can respond positively to exercise and stress and rejuvenate even into older age, showing remarkable plasticity (<xref ref-type="bibr" rid="bib6">Cartee et al., 2016</xref>; <xref ref-type="bibr" rid="bib14">Distefano and Goodpaster, 2018</xref>; <xref ref-type="bibr" rid="bib45">Pollock et al., 2018</xref>). A molecular study of muscle aging and plasticity in a genetically tractable model could shed light on the fundamental aspects of these processes.</p><p>microRNAs are small 22–26 nucleotide RNAs that bind with complementarity through their seed sequence to target mRNAs to downregulate gene expression (<xref ref-type="bibr" rid="bib20">Gu and Kay, 2010</xref>). They can work as molecular switches or fine-tune gene regulation, and typically have multiple targets, thereby coordinating cellular programs. Many microRNAs are expressed in a tissue-specific manner and regulate programs cell autonomously, and could therefore potentially serve as tissue-specific therapeutic targets (<xref ref-type="bibr" rid="bib21">Guo et al., 2015</xref>; <xref ref-type="bibr" rid="bib43">Panwar et al., 2017</xref>). In addition, some microRNAs are found circulating in serum (<xref ref-type="bibr" rid="bib8">Chen et al., 2008</xref>; <xref ref-type="bibr" rid="bib56">Weber et al., 2010</xref>), raising the possibility that they can act cell non-autonomously as well.</p><p>miR-1 homologs are muscle-enriched microRNAs that are highly conserved in evolution and important for mammalian heart and muscle development (<xref ref-type="bibr" rid="bib61">Zhao et al., 2007</xref>). Like in other animals, <italic>Caenorhabditis elegans mir-1</italic> is expressed in body wall (‘skeletal’) and pharyngeal (‘cardiac’) muscle (<xref ref-type="bibr" rid="bib51">Simon et al., 2008</xref>). Deletion mutants are viable and exhibit modest changes in the behavior of the neuromuscular junction (<xref ref-type="bibr" rid="bib51">Simon et al., 2008</xref>) and autophagy (<xref ref-type="bibr" rid="bib41">Nehammer et al., 2019</xref>), but little else is known of its normative function. In this work, we examined the potential role of miR-1 in regulating muscle function and proteostasis. Surprisingly, we found that under polyQ35 proteotoxic challenge, <italic>mir-1</italic> mutation prevents aggregate formation and increases organismal motility and pharyngeal contractility during aging. Mechanistically, miR-1 regulates expression of several lysosomal v-ATPase subunits and targets a crucial regulatory component, <italic>vha-13</italic>/ATP6V1A, via its 3′UTR to impact proteotoxicity and longevity. Further, miR-1 regulates lysosomal acidification and nuclear localization of HLH-30/TFEB, a key regulator of lysosome biogenesis. These studies reveal an unexpected role of miR-1 in coordinating lysosomal function and health during aging.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>mir-1</italic> mutation improves muscle motility upon polyQ35 challenge</title><p><italic>mir-1</italic> is a highly conserved microRNA expressed predominantly in <italic>C. elegans</italic> muscle tissues including pharyngeal muscle, body wall muscle, and sex muscles (<xref ref-type="bibr" rid="bib1">Andachi and Kohara, 2016</xref>; <xref ref-type="bibr" rid="bib35">Martinez et al., 2008</xref>). While microRNAs are known as important developmental regulators (<xref ref-type="bibr" rid="bib27">Ivey and Srivastava, 2015</xref>), miR-1 expression also persists throughout adulthood, declining by half from day 1 to day 14 of adulthood (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>, data from <xref ref-type="bibr" rid="bib62">Zhou et al., 2019</xref>). To unravel molecular miR-1 function, we first characterized the nature of several <italic>mir-1</italic> mutations. The reference alleles (<italic>n4101, n4102</italic>) consist of large deletions of the region that could have confounding effects on nearby loci. We therefore focused on <italic>gk276</italic>, a smaller 192 base pair deletion that removes the <italic>mir-1</italic> coding region as well as the downstream non-coding region, and used this deletion in our experiments. We also generated an independent <italic>mir-1</italic> allele, <italic>dh1111,</italic> by CRISPR genome engineering (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), which deletes a 53 base pair region within the <italic>mir-1</italic> locus. Both alleles failed to express the mature miRNA as measured by TaqMan qPCR (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>), and thus are <italic>mir-1</italic> null mutants.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>mir-1</italic> mutants exhibit improved motility upon polyQ35 challenge.</title><p>(<bold>A</bold>) Schematic showing the <italic>mir-1</italic> locus, deletion alleles <italic>mir-1(gk276</italic>) and <italic>mir-1(dh1111)</italic> (see Materials and methods). (<bold>B</bold>) Representative images of N2 wild-type (WT) and <italic>mir-1</italic> mutant animals expressing <italic>unc-54p::Q35::YFP</italic> (Q35) showing loss of aggregates in the <italic>mir-1</italic> background on day 4 of adulthood. Arrowheads point to aggregates. Scale bar 100 μm. (<bold>C</bold>) Quantification of Q35::YFP aggregates in (<bold>B</bold>). Each dot represents one animal, mean ± SEM from one representative experiment, N = 3, one-way ANOVA, Tukey’s multiple comparisons test, *** p&lt;0.001, ****p&lt;0.0001, ns, not significant. (<bold>D</bold>) Motility of indicated <italic>mir-1</italic> alleles and N2 (WT) animals expressing <italic>unc-54p::Q35::YFP</italic>, measured by the circle test, day 8 of adulthood. Percent worms that left the circle after 30 min. Each dot represents one experiment. Mean ± SEM of N = 6–8. One-way ANOVA, ***p&lt;0.001, ****p&lt;0.0001, ns, not significant. (<bold>E</bold>) Motility of <italic>mir-1</italic> alleles and N2 animals expressing <italic>unc-54p::Q35::YFP</italic>, measured by the thrashing assay. 25 worms per condition, each dot represents one animal, mean ± SEM from one representative experiment, N = 4, one-way ANOVA, **p&lt;0.01 ***p&lt;0.001, ns, not significant. CeleST analysis of activity index (<bold>F</bold>), brush stroke (<bold>G</bold>), and body wave number (<bold>H</bold>) comparing N2 and <italic>mir-1(gk276)</italic> mutant animals with or without <italic>unc-54p::Q35::YFP</italic> at days 4 and 8 of adulthood. Each dot represents one animal. t-test, *p&lt;0.05 **p&lt;0.01, ns, not significant. (<bold>I</bold>) Pharyngeal pumping rate measured on day 8 of adulthood in <italic>mir-1</italic> alleles and WT animals expressing <italic>unc-54p::Q35::YFP.</italic> Each dot represents one animal, mean ± SEM from one representative experiment, N = 3, one-way ANOVA, ****p&lt;0.0001, ns, not significant. (<bold>J</bold>) Life span experiments of <italic>mir-1</italic> mutants and N2 animals expressing <italic>unc-54P::Q35::YFP.</italic> One experiment of N = 3. Log-rank test: N2;Q35 vs<italic>. gk276</italic>;Q35: p=0.03. N2;Q35 vs. <italic>dh1111</italic>;Q35: p&lt;0.0001. (<bold>K</bold>) Presence of an extrachromosomal <italic>mir-1</italic> transgene brings back aggregates in <italic>mir-1(gk276)</italic> mutants at day 4 of adulthood, showing rescue by the transgene. Transgenic worms were compared to non-transgenic segregants of the same strain. Scale bar 100 μm. (<bold>L</bold>) Quantification of <italic>Q35::YFP</italic> aggregates (from <bold>K</bold>), each dot represents total aggregate number of one animal, mean ± SEM from one representative experiment, N = 3, t-test, ****p&lt;0.0001. (<bold>M</bold>) Motility of <italic>mir-1(gk276)</italic>;Q35 animals in the presence or absence of the <italic>mir-1</italic> transgene at day 8 of adulthood, measured by circle test. Transgenic worms were compared to non-transgenic segregants of the same strain. Each dot represents one experiment, mean ± SEM of N = 7. t-test, **p&lt;0.01. (<bold>N</bold>) Pharyngeal pumping rate of <italic>mir-1(gk276)</italic>; Q35 animals in the presence or absence of the <italic>mir-1</italic> transgene. Transgenic worms were compared to non-transgenic segregants of the same strain. Each dot represents one animal, mean ± SEM from one representative experiment, N = 7, t-test, **p&lt;0.01. (<bold>O</bold>) Life span experiments of <italic>mir-1(gk276)</italic>;Q35 animals in the presence or absence of the <italic>mir-1</italic> transgene. Transgenic worms were compared to non-transgenic segregants of the same strain. One representative experiment of N = 5, log-rank test, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66768-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Characterization of <italic>mir-1</italic> mutant physiology under normal conditions and proteotoxic models.</title><p>(<bold>A</bold>) MicroRNA-seq analysis of miR-1 in wild-type (WT) worms of indicated ages (<xref ref-type="bibr" rid="bib62">Zhou et al., 2019</xref>). Normalized miR-1 reads of three independent experiments for samples of days 1, 7, 14, and 21 of adulthood, respectively. Mean ± SEM. (<bold>B</bold>) TaqMan qPCR measuring mature miR-1 levels show that the deletion alleles do not express <italic>mir-1</italic> and are null, N = 2 BR. Mean ± SEM, one-way ANOVA, *p&lt;0.05. (<bold>C</bold>) Brood size of <italic>mir-1(gk276)</italic> and <italic>mir-1(dh1111)</italic> compared to N2 WT worms. Each dot represents the brood size of one worm, mean ± SEM, one-way ANOVA, ns, not significant. (<bold>D</bold>, <bold>E</bold>) Life span experiments performed at 20°C and 25°C for two <italic>mir-1</italic> deletion alleles compared to WT (N2). N = 3, log-rank test, ns, not significant (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). (<bold>F</bold>,<bold> G</bold>) Motility of WT and <italic>mir-1(gk276)</italic> mutant animals on day 14 of adulthood, measured by circle test (<bold>F</bold>) and thrashing in liquid (<bold>G</bold>). One representative experiment of each N = 3 is shown. Mean ± SEM, one-way ANOVA, ns, not significant. (<bold>H</bold>) Heat stress survival at 35°C of day 1 <italic>mir-1(gk276)</italic> and <italic>mir-1(dh1111)</italic> mutants compared to WT. One representative experiment is shown, N = 3, log-rank test: N2 vs<italic>. gk276</italic>: p = 0.20. N2 vs<italic>. dh1111</italic>: p=0.17. (<bold>I</bold>–<bold>M</bold>) CeleST locomotion behavior analyses of WT and <italic>mir-1(gk276)</italic> mutant animals with or without <italic>unc-54p::Q35::YFP</italic> at days 4 and 8 of adulthood. Each dot represents one animal. (<bold>I</bold>) Travel speed, (<bold>J</bold>) wave initiation rate, (<bold>K</bold>) asymmetry, (<bold>L</bold>) stretch, and (<bold>M</bold>) curling. t-test, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ns, not significant. (<bold>N</bold>) Bar graph showing the expression level of mature miR-1 microRNA in the indicated genotypes. N = 1 biological replicate, four technical replicates. (<bold>O</bold>) Thrashing motility of α-syn and <italic>mir-1(gk276)</italic>; α-syn worms at days 1 and 5 of adulthood. N = 3 biological replicates, t-test, **p&lt;0.01, ns, not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66768-fig1-figsupp1-v1.tif"/></fig></fig-group><p>To investigate <italic>mir-1</italic> function, we measured several physiological parameters. We found that <italic>mir-1</italic> mutants <italic>gk276</italic> and <italic>dh1111</italic> developed normally, had normal brood size, and near normal life span (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C–E</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). Additionally, motility on solid media, thrashing in liquid medium, and pharyngeal pumping ability determined at days 8 and 14 of adulthood were similar to N2 wild-type (WT) controls (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F, G</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Since <italic>mir-1</italic> deletion showed little obvious phenotype on its own, we reasoned that some physiological differences might emerge under stress conditions, hence we tested heat and proteotoxic stress. We saw little distinction from WT with moderate heat stress by growth at 25°C nor heat shock resistance at 35°C (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E, H</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>).</p><p>We next tested the idea that <italic>mir-1</italic> mutants might differ in their response to proteotoxic stress. To do so, we used a strain expressing polyglutamine-35 tracts fused to yellow fluorescent protein (YFP) under the control of the muscle myosin-specific <italic>unc-54</italic> promoter (<italic>unc-54p::Q35::YFP</italic>), which has been used previously in models of proteotoxicity and Huntington’s disease (<xref ref-type="bibr" rid="bib5">Brignull et al., 2006</xref>; <xref ref-type="bibr" rid="bib39">Morley et al., 2002</xref>). In these strains, initially soluble proteins become sequestered into insoluble aggregates, visible as foci in the muscle of the worm. Worms expressing the polyQ35 stretches showed progressive age-dependent protein aggregation, which became clearly visible by day 4 of adulthood. Interestingly, we observed that <italic>mir-1</italic> mutants displayed significantly less aggregates (avg. 38 and 36, day 4 of adulthood) compared to age-matched WT controls (avg. 53) at this time (<xref ref-type="fig" rid="fig1">Figure 1B, C</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>).</p><p>We further investigated the possible effect of proteotoxicity by measuring organismal motility of Q35 strains using the circle test. This test measures how many worms crawl out of a 1 cm circle within 30 min on day 8 of adulthood on agar plates. Day 8 was chosen as a timepoint where paralysis becomes visible, but animals are still viable. We observed that about 30% of the <italic>mir-1;</italic>Q35 mutants left the circle while only 2.5% of the control Q35 worms did so (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). We also measured motility by counting the thrashing rate in liquid medium on day 8 of adulthood. Though the degree of paralysis was more variable, both <italic>mir-1</italic> mutants <italic>gk276</italic> and <italic>dh1111</italic> were significantly more mobile (avg. 16, 15 body bends) compared to age-matched Q35 controls (avg. two body bends, <xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>).</p><p>To further characterize miR-1’s impact on muscle function, we performed CeleST analysis (<xref ref-type="bibr" rid="bib46">Restif et al., 2014</xref>), a MATLAB-based algorithm that extracts various parameters of movement (wave initiation, travel speed, brush stroke, activity index) and gait (wave number, asymmetry, curl, stretch) from video footage. Typically activity measures decline with age, whereas gait abnormalities increase with age (<xref ref-type="bibr" rid="bib46">Restif et al., 2014</xref>). We scored animals focusing on days 4 and 8 of adulthood comparing <italic>mir-1(gk276)</italic> and WT in the presence and absence of the Q35 array. In the absence of Q35, <italic>mir-1</italic> mutants performed similar to WT (e.g., body wave) or were slightly different (wave initiation, travel speed, stretch) for some parameters (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>). In the presence of Q35, however, <italic>mir-1(gk276)</italic> mutants did significantly better than WT for several measures of activity (activity index, brush stroke, travel speed, wave initiation rate) and gait (number of body waves) on day 8 (<xref ref-type="fig" rid="fig1">Figure 1F–H</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1I–M</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>), consistent with the idea that <italic>mir-1</italic> mutation protects against Q35 proteotoxic stress during mid-life. <italic>mir-1</italic> is also highly expressed in the pharynx, a contractile tissue similar to cardiac muscle. We observed that the pumping rate of <italic>mir-1</italic>;Q35 worms was significantly increased (<italic>gk276</italic>, avg. 60; <italic>dh1111</italic>, avg. 78) compared to Q35 controls (avg. 16) on day 8 of adulthood (<xref ref-type="fig" rid="fig1">Figure 1L</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Furthermore, we found that the life span of <italic>mir-1(dh1111)</italic>;Q35 strains was significantly extended (n = 3, mean 13 [WT] vs. 19 [<italic>dh1111]</italic> days) compared to Q35 alone (<xref ref-type="fig" rid="fig1">Figure 1J</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). A similar trend was seen with <italic>gk276</italic> in two out of three experiments (<xref ref-type="fig" rid="fig1">Figure 1J</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). These findings suggest that <italic>mir-1</italic> reduction can counter the intrinsic and systemic detrimental effects of Q35 proteotoxic challenge.</p><p>Introducing a WT <italic>mir-1</italic> transgene into the <italic>mir-1(gk276)</italic> background restored normal levels of mature miR-1 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1N</xref>) and largely reversed <italic>mir-1</italic> phenotypes, showing increased Q35 aggregates, decreased motility, pumping rate, and life span compared to non-transgenic controls (<xref ref-type="fig" rid="fig1">Figure 1K–O</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a, b</xref>). The similarity of behavior among the different <italic>mir-1</italic> alleles and the rescue of these phenotypes by the WT <italic>mir-1</italic> transgene demonstrates that the <italic>mir-1</italic> mutation is causal for removing muscle aggregates and improving mid-life motility.</p><p>To determine whether <italic>mir-1</italic> loss generally protects against proteotoxic stress, we examined two other muscle-specific proteotoxic models: polyQ40 and human α-synuclein (α-syn). In contrast to polyQ35, which forms aggregates during adulthood, polyQ40 aggregates were already visible during development. We found aggregate numbers significantly reduced in <italic>mir-1(gk276)</italic>;Q40 L4 worms (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). However, the motility of <italic>mir-1(gk276)</italic>;Q40 worms, determined by 1 min thrashing assays, was unaffected at day 3 of adulthood and reduced in two out of three experiments at day 7 of adulthood compared to Q40 controls (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Similarly, aggregate numbers were reduced in <italic>mir-1(gk276)</italic>;α-syn worms at day 1 of adulthood compared to the α-syn control (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Thrashing of <italic>mir-1(gk276)</italic>;α-syn worms was significantly reduced on day 1 of adulthood, but by day 5 there was no significant difference in motility between <italic>mir-1(gk276)</italic>;α-syn and α-syn worms (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1O</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Taken together, <italic>mir-1</italic> loss reduced aggregate numbers in three different proteotoxic stress paradigms. However, reduced number of aggregates did not always directly correlate with improved motility, reinforcing the notion that protein aggregation may promote or aggravate health depending on the proteotoxic species and age (<xref ref-type="bibr" rid="bib11">Cohen et al., 2006</xref>).</p></sec><sec id="s2-2"><title>v-ATPase subunits are downstream mediators of miR-1-induced motility improvement</title><p>To identify downstream mediators of protein quality control improvement in <italic>mir-1</italic> mutants, we used computational and proteomic approaches to find potential miR-1 targets. For the computational approach, we used publicly available prediction tools to identify genes harboring miR-1 seed binding sites in their 3′UTR, namely <ext-link ext-link-type="uri" xlink:href="http://microrna.org/">microRNA.org</ext-link>, TargetScanWorm, and PicTar (<xref ref-type="bibr" rid="bib2">Betel et al., 2008</xref>; <xref ref-type="bibr" rid="bib28">Jan et al., 2011</xref>; <xref ref-type="bibr" rid="bib30">Lall et al., 2006</xref>). These prediction tools use distinct algorithms that often yield different and extensive sets of candidates (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Therefore, we limited ourselves mostly to candidates that were predicted as targets by all three algorithms. This yielded 68 overlapping candidates (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>). Interestingly, network analysis of these 68 genes using STRING (<ext-link ext-link-type="uri" xlink:href="https://string-db.org/">string-db.org</ext-link>) (<xref ref-type="bibr" rid="bib52">Snel et al., 2000</xref>) revealed a tight cluster of predicted targets encoding 11/21 subunits of the vacuolar ATPase (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Five additional vacuolar ATPase genes were identified by two of the three prediction algorithms (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). In addition, two genes that code transcription factors implicated in lysosome biogenesis, <italic>daf-16</italic>/FOXO and <italic>hlh-30</italic>/TFEB (<xref ref-type="bibr" rid="bib48">Sardiello et al., 2009</xref>; <xref ref-type="bibr" rid="bib49">Settembre et al., 2011</xref>), also contained predicted miR-1 binding sites in their 3′UTRs.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>v-ATPase subunits are downstream mediators of <italic>mir-1-</italic>induced motility improvement.</title><p>(<bold>A</bold>) Computational screen for potential miR-1 targets using in silico predictions <ext-link ext-link-type="uri" xlink:href="http://microrna.org/">microRNA.org</ext-link>, TargetScanWorm (TargetScan), and PicTar identifies 68 shared candidates. (<bold>B</bold>) STRING network analysis of predicted miR-1 targets reveals a cluster of v-ATPase subunits. (<bold>C</bold>) Initial RNAi screen of computationally predicted candidates using the circle test on day 8 of adulthood reveals a number of candidates that reduced motility of <italic>mir-1(gk276)</italic>;Q35. 20 worms per RNAi (N = 1). Red line: number of luciferase controls that left the circle. v-ATPases are highlighted in red. (<bold>D</bold>) Volcano plot of proteomic analysis showing differentially regulated proteins in <italic>mir-1(gk276)</italic> vs. N2 animals. VHA-10 and VHA-19 are indicated by blue triangles. Red dots and blue triangles show upregulated proteins tested in circle assay. N = 6 (<italic>mir-1</italic>) and 4 (N2) biological replicates. (<bold>E</bold>) Effect of v-ATPase subunit RNAi knockdown on <italic>mir-1(gk276)</italic>;Q35 motility as measured in the thrashing assay. Animals are grown on the corresponding RNAi from L4 onwards. N = 1. Mean ± SEM, one-way ANOVA, only significant values are labeled: *p&lt;0.05, **p&lt;0.01. (<bold>F</bold>, <bold>G</bold>) Motility assay (circle test) and thrashing assay on day 8 of <italic>mir-1(gk276)</italic>;Q35 worms upon <italic>vha-13, vha-5, daf-16,</italic> and <italic>hlh-30</italic> RNAi knockdown. Control, luciferase RNAi (<italic>luci</italic>). Mean ± SEM of N = 4, one-way ANOVA, *p&lt;0.05, ***p&lt;0.001, ****p&lt;0.0001, ns, not significant. (<bold>H</bold>) Pumping assay of <italic>mir-1(gk276)</italic>;Q35 worms upon <italic>vha-13, vha-5, daf-16,</italic> and <italic>hlh-30</italic> RNAi knockdown on day 8 of adulthood. Control, luciferase RNAi (<italic>luci</italic>). N = 3, mean ± SEM, one-way ANOVA, **p&lt;0.01, ns, not significant. (<bold>I</bold>) Life span of <italic>mir-1(gk276)</italic>;Q35 and Q35 worms upon <italic>vha-13</italic> RNAi knockdown. Control, luciferase RNAi (<italic>luci</italic>). One experiment of N = 3, log-rank test: p&lt;0.01.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66768-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Bioinformatic and proteomic screens implicate v-ATPase subunits as downstream mediators of <italic>mir-1</italic>-induced motility improvement.</title><p>(<bold>A</bold>) v-ATPase subunits containing one or two predicted miR-1 binding sides (BS) in their 3′UTR. v-ATPase genes identified in the bioinformatic screen by all three databases are labeled 'B,' by two databases are labeled (B), and by the proteomic screen are labeled 'P.' (<bold>B</bold>) Correlation plot of the biological replicates from proteomics showing the similarity of wild-type WT (N2) and <italic>mir-1(gk276)</italic> genotypes. (<bold>C</bold>) RNAi screen for genes required for <italic>mir-1(gk276)</italic>;Q35 motility in the circle test, using upregulated genes from the proteomic analysis (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e, f</xref>). Each dot represents the percentage of worms that left the circle. Red line: percent luciferase controls that left the circle; Nd: not determined. Validation of selected candidates identified from bioinformatic (<bold>D</bold>) and (<bold>E</bold>) proteomic screens by thrashing assay on day 8 of adulthood. <italic>mir-1(gk276)</italic>;Q35 worms were grown on the corresponding RNAi from L4 onwards. Each dot represents one animal, 15 worms per RNAi. Mean ± SEM, one-way ANOVA, only significant values are labeled: *p&lt;0.05. (<bold>F</bold>) Motility of worms in circle test of indicated RNAi on N2;Q35 worms. Motility was measured on day 5 of adulthood, each dot represents the percentage of worms that left the circle. Mean ± SEM of one representative experiment, N = 3, one-way ANOVA, ***p&lt;0.001, ns, not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66768-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Next, we carried out a functional screen of the selected candidates. We reasoned that <italic>mir-1</italic> deletion likely results in an upregulation of these proteins, and that RNAi knockdown of the relevant genes should therefore abrogate the improved motility of <italic>mir-1</italic>;Q35 worms. Specifically, we tested 44 available RNAi clones (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref>) and scored motility using a rapid version of the circle test, measuring the ability of <italic>mir-1</italic>;Q35 worms grown on candidate RNAis to migrate out of a 1 cm diameter circle within 1 min (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). 12/20 <italic>mir-1</italic>;Q35 worms left the circle when grown on luciferase control RNAi (<italic>luci)</italic>. We considered genes as potential <italic>mir-1</italic>;Q35 suppressors if less than four worms left the circle upon RNAi knock down of the genes and prioritized candidates when only zero or one worm left. Among the selected candidates, vacuolar ATPase subunits <italic>vha-1, vha-8, vha-9, vha-13,</italic> and <italic>vha-14</italic>, as well as muscle gene <italic>zyx-1</italic>, stood out as molecules suppressing <italic>mir-1</italic> motility (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>).</p><p>As a parallel approach to identify miR-1 regulatory targets in an unbiased manner, we performed TMT shotgun proteomic analysis, comparing <italic>mir-1</italic> mutants to WT worms on day 1 of adulthood. We identified approximately 1500–2000 proteins in the replicates (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1f</xref>). Samples showed a high degree of correlation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>) with minimal separation of WT and <italic>mir-1</italic> genotypes, reflecting the subtle changes induced by <italic>mir-1</italic> mutation at the organismal level. For further analysis, we therefore selected the 50 top upregulated proteins with available RNAi clones and tested them for their ability to suppress the motility phenotype using the circle test (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C, E</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref>), among them <italic>vha-10</italic>, <italic>vha-19,</italic> and <italic>zyx-1</italic>, which had previously been predicted to harbor <italic>mir-1</italic> binding sites.</p><p>Based on the prominence of v-ATPase genes among both the informatic and the proteomic candidates, we systematically tested 10 of them in the thrashing assay, confirming v-ATPase subunits <italic>vha-1, vha-9, vha-13, vha-14,</italic> and <italic>vha-19</italic> as likely mediators of <italic>mir-1</italic>;Q35 motility (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). We further tested the impact of <italic>vha-5</italic> and <italic>vha-13 on mir-1</italic>;Q35 phenotypes in more detail, as well as transcription factors <italic>daf-16/FOXO</italic> and <italic>hlh-30/TFEB</italic> as potential miR-1 targets that mediate lysosomal biogenesis. Using the circle test, thrashing assay, and pharyngeal pumping as readout (<xref ref-type="fig" rid="fig2">Figure 2F–H</xref>), we again verified in particular the role of <italic>vha-13</italic> in reducing <italic>mir-1</italic> motility. In addition, <italic>daf-16/FOXO</italic> and <italic>hlh-30/TFEB</italic> RNAi reduced motility as measured in the circle test, indicating a potential requirement for these transcription factors. We also confirmed that the effect on motility was specific to the <italic>mir-1</italic> background for <italic>vha-5</italic>, <italic>vha-13,</italic> and <italic>hlh-30</italic> since RNAi of these genes had no significant effect on motility in N2;Q35 worms (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>).</p><p>In summary, knockdown of 5 out of 10 tested v-ATPase subunits from both the computational and proteomics screen, as well as two transcriptional mediators of lysosome biogenesis, reduced or abolished <italic>mir-1</italic> motility improvement either by circle test or thrashing, revealing these molecules to have congruent physiological effects. Therefore, we focused most of our further efforts on examining v-ATPase regulation by miR-1.</p></sec><sec id="s2-3"><title>miR-1 directly regulates VHA-13 protein levels in muscle tissue</title><p>MicroRNAs regulate their targets by binding to the 3′UTR of client mRNAs, thereby decreasing RNA stability and translation. If miR-1 regulates v-ATPase subunits, then miR-1 loss would be predicted to de-repress v-ATPase mRNA and protein levels. Because the onset of Q35 aggregation becomes visible by day 4 of adulthood, we examined the mRNA expression of representative v-ATPase subunits at this time. We found that the mRNA levels of <italic>vha-5, vha-10, vha-13</italic>, and <italic>vha-19,</italic> as well as transcription factors <italic>hlh-30</italic>/TFEB and <italic>daf-16</italic>/FOXO, were increased approximately twofold in <italic>mir-1</italic> mutants compared to age-matched WT worms (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), consistent with the idea that these genes are miR-1 targets.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>miR-1 directly regulates <italic>vha-13</italic> via its 3′UTR in muscle tissue.</title><p>(<bold>A</bold>) RT-qPCR of <italic>vha-5, vha-10, vha-13,</italic> and <italic>vha-19</italic>, as well as <italic>daf-16</italic> and <italic>hlh-30</italic> mRNA levels in wild-type (WT) (N2) and <italic>mir-1(gk276)</italic> mutants on day 4 of adulthood. Mean ± SEM, N = 3–4, one-way ANOVA, **p&lt;0.01, ***p&lt;0.001. (<bold>B</bold>) Expression pattern of endogenously tagged <italic>3xFlag::mNeonGreen::vha-13</italic> in pharynx, excretory cell and canal, gut, vulva muscle (vum), hypodermis, and muscle (arrowheads indicate dense bodies). (<bold>C</bold>) Confocal images of the head region in worms carrying endogenously tagged <italic>3xFlag::mNeonGreen::vha-13</italic> in late L4 <italic>mir-1(gk276)</italic> and WT (N2) animals at 25°C. Red rectangle highlights the area of <italic>vha-13</italic> expression in the isthmus used for determination of mNeonGreen intensity. Scale bar 20 μm. (<bold>D</bold>) Quantification of fluorescent intensity of 3xFlag::mNeonGreen::VHA-13 in the isthmus of indicated genotypes (as shown in <bold>C</bold>) in late L4 larvae at 25°C. Mean ± SEM of N = 5, t-test, **p&lt;0.01. (<bold>E</bold>) Quantification of fluorescent intensity of 3xFlag::mNeonGreen::VHA-13 in the isthmus of N2 in the presence or absence of the <italic>mir-1</italic> transgene in late L4 larvae at 25°C. Transgenic worms (<italic>mir-1</italic> transgene) were compared to non-transgenic segregants (N2) of the same strain. Mean ± SEM of N = 4, t-test, ***p&lt;0.001. (<bold>F</bold>) Graphic showing the 3′UTR of endogenously tagged <italic>3xFlag::mNeonGreen::vha-13. vha-13 wt: vha-13</italic> WT 3′UTR. <italic>vha-13 MUT1</italic>: one miR-1 binding site (BS) is mutated. <italic>vha-13 MUT2</italic>: both miR-1 BSs are mutated. <italic>unc-54 3’UTR</italic>: the <italic>vha-13 3′UTR</italic> is substituted by <italic>unc-54 3′UTR</italic>. Nucleotide sequences of mutated miR-1 BSs are shown below WT. (<bold>G</bold>) Quantification of fluorescence intensity in the isthmus of L4 larvae with endogenously tagged <italic>3xFlag::mNeonGreen::vha-13</italic> of <italic>vha-13 MUT2 3′UTR</italic> in relation to <italic>vha-13 wt 3′UTR</italic>, in N2 and <italic>mir-1(gk276)</italic> mutant backgrounds at 25°C, using confocal imaging. Mean ± SEM of N = 3, one representative experiment, one-way ANOVA, ****p&lt;0.0001, ns, not significant. (<bold>H</bold>) Western blot image of late L4 WT and <italic>mir-1</italic> mutants expressing transgenic Flag-tagged <italic>vha-13</italic> in body wall muscle (<italic>myo-3p::vha-13</italic>) with either the <italic>unc-54 3′UTR</italic> (labeled in red), which lacks miR-1 BSs, or the wt <italic>vha-13 3′UTR,</italic> which contains the two miR-1 BSs (labeled in black), immunoblotted with anti-Flag and anti-Histone H3 antibodies. Histone H3 loading control is shown below. Biological replicates (N = 3) separated by dashed lines. (<bold>I</bold>) Quantification of western blot shown in (<bold>H</bold>), with flag-tag intensity normalized to histone H3 loading control, mean ± SEM of N = 3, one-way ANOVA, ***p&lt;0.001, ns, not significant. (<bold>J</bold>) Quantification of aggregates in Q35 worms expressing transgenic <italic>vha-13</italic> in the body wall muscle (<italic>myo-3p::vha-13 wt</italic>;Q35) or non-transgenic segregants (Q35) of the same strain. 25 worms per genotype, mean ± SEM of one representative experiment, N = 4, t-test, ***p&lt;0.001. (<bold>K</bold>) Motility of Q35 worms expressing transgenic <italic>vha-13</italic> in the body wall muscle (<italic>myo-3p::vha-13 wt</italic>;Q35) or non-transgenic segregants (Q35) of the same strain in circle test. Mean ± SEM. One experiment of N = 2, t-test, ***p&lt;0.001. (<bold>L</bold>) Pharyngeal pumping rate of <italic>myo-3p::vha-13 wt</italic>;Q35 and Q35 non-transgenic segregants of the same strain. One representative experiment of N = 4, mean ± SEM, t-test, ***p&lt;0.001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66768-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>miR-1 regulates <italic>vha-13 </italic>via its 3' UTR and its regulation may be evolutionarily conserved.</title><p>(<bold>A</bold>) Quantification of pharyngeal fluorescent intensity of endogenous 3xFlag::mNeonGreen::VHA-5 in indicated genotypes in late L4s maintained at 25°C. One representative experiment of N = 3, mean ± SEM, t-test, ***p&lt;0.001. (<bold>B</bold>) Quantification of fluorescent intensity of <italic>3xFlag::mNeonGreen::vha-5</italic> expression in the vulva of indicated genotypes. Mean ± SEM of N = 3, t-test, ns, not significant. (<bold>C</bold>) Schematic showing the conservation of miR-1 binding sites (BS) in the <italic>vha-13</italic> 3′UTR of different nematode species. (<bold>D</bold>) Images showing expression of endogenously tagged 3xFlag::mNeonGreen::VHA-13 in muscle dense body and hypodermis. Arrows indicate individual dense bodies. Rectangle highlights muscle section shown in <xref ref-type="fig" rid="fig3">Figure 3B</xref>. (<bold>E</bold>) Quantification of fluorescence intensity in the isthmus of L4 larvae with endogenously tagged <italic>3xFlag::mNeonGreen::vha-13</italic> with <italic>vha-13 MUT1 3′UTR</italic> in relation to vha-13 wt 3′UTR, in N2 and <italic>mir-1(gk276)</italic> backgrounds using confocal microscopy. Mean ± SEM of one representative experiment. N = 2, one-way ANOVA, ****p&lt;0.00001, ns, not significant. (<bold>F</bold>) Thrashing assay of <italic>unc-54p::Q35::YFP</italic> (Q35) worms expressing <italic>vha-13</italic> in body wall muscle (<italic>myo3p::vha-13</italic> wt;Q35) or non-transgenic Q35 animals. 25 worms per genotype, mean ± SEM of one representative experiment, N = 4, t-test, ****p&lt;0.0001. (<bold>G</bold>) Life span of Q35 worms overexpressing <italic>vha-13</italic> in the body wall muscle (<italic>myo3p::vha-13</italic> wt;Q35) and Q35 non-transgenic segregants of the same strain. One experiment of N = 4. Life span effects of two experiments were significant (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). Log-rank test, p=0.0017. (<bold>H</bold>) <italic>Atp6v1a</italic> and <italic>Atp6v1h</italic> mRNA expression in mouse skeletal muscle from WT and muscle-specific miR-1/miR-133a double knockout (dko) mice (dataset from <xref ref-type="bibr" rid="bib58">Wüst et al., 2018</xref>, N = 3 mice per genotype, **q [adjusted p-value] &lt; 0.01). (<bold>I</bold>) <italic>Atp6v1a</italic> mRNA expression in hearts from WT and miR-1-1/miR1-2 double knockout (dko) mice (dataset from <xref ref-type="bibr" rid="bib57">Wei et al., 2014</xref>, *q [adjusted p-value] &lt; 0.05).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66768-fig3-figsupp1-v1.tif"/></fig></fig-group><p>We further investigated whether miR-1 regulates these gene products at the protein level. We endogenously tagged <italic>vha-5, vha-10, vha-13</italic>, and <italic>vha-19</italic> (N-terminus) with 3xFlag-mNeonGreen-tag as well as <italic>hlh-30</italic> (C-terminus) with mNeonGreen-tag by CRISPR/Cas9 genome editing. Tagging <italic>vha-19</italic> and <italic>vha-10</italic> caused lethality and was not pursued further. Tagged <italic>vha-5</italic> showed significant upregulation in the pharynx in <italic>mir-1(gk276)</italic> mutants compared to WT, but not in vulva muscle (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>). However, <italic>vha-5</italic> RNAi knockdown had no significant difference in motility compared to controls (<xref ref-type="fig" rid="fig2">Figure 2E–G</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Further, we saw no obvious regulation of endogenously tagged HLH-30 protein levels in the pharynx in late L4 larvae or day 4 adults (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, B</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>), though we did see increased nuclear localization in the hypodermis in day 4 <italic>mir-1(gk276)</italic> adults (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>mir-1</italic> mutation enhances lysosomal biogenesis and acidification.</title><p>(<bold>A</bold>) Fluorescent image comparing HLH-30::mNeonGreen nuclear localization in the hypodermis of the <italic>mir-1(gk276)</italic> and wild-type (WT) (N2) backgrounds at day 4 of adulthood, maintained at 25°C. Scale bar 20 μm. (<bold>B</bold>) Quantitation of nuclear localization in (<bold>A</bold>). Violin plot, mean ± SEM of one representative experiment of N = 3, t-test, **** p&lt;0.0001. (<bold>C</bold>) Western blot of LMP-1::GFP in WT and <italic>mir-1</italic> mutants at the L4 stage, immunoblotted with anti-GFP or anti-α-tubulin antibodies. Biological replicates (N = 3) separated by dashed lines. (<bold>D</bold>) Quantification of the western blot in (<bold>C</bold>), normalized to α-tubulin loading control. N = 3 BR, line and error bars indicate mean ± SEM, t-test, **p&lt;0.01. (<bold>E</bold>) Representative images of lysotracker staining in WT and <italic>mir-1(gk276)</italic> mutants at day 4 of adulthood at 25°C. Scale bar 20 μm. (<bold>F</bold>) Quantification of lysotracker images using a predefined squared area approximately spanning the second to fourth gut cell. Quantification was performed using ImageJ. N = 3 BR, line and error bars indicate mean ± SEM of combined experiments, t-test, *p&lt;0.05. (<bold>G</bold>) Working model. miR-1 normally limits proteoprotective pathways, downregulating the expression of <italic>vha-13,</italic> other v-ATPases and factors by binding miR-1 binding site(s) in the 3′UTR (miR-1 BS) of the corresponding mRNA (WT, polyQ35 proteotoxic stress). Loss of miR-1 (<italic>mir-1</italic> knockout, polyQ35 proteotoxic stress) results in de-repression of <italic>vha-13</italic> and elevated lysosomal activity. Nuclear localization of HLH-30/TFEB, a master regulator of lysosome biogenesis, is also enhanced, collectively resulting in reduced number of aggregates under polyQ35 proteotoxic stress conditions.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66768-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title><italic>mir-1</italic> mutation does not affect total expression of HLH-30 in the pharynx.</title><p>(<bold>A</bold>) Fluorescent image comparing HLH-30::mNeonGreen intensity in the pharynx of the <italic>mir-1(gk276)</italic> and wild-type (WT) (N2) backgrounds in L4s (top) or day 4 adults (bottom), grown at 25°C. Scale bar 20 μm. (<bold>B</bold>) Quantitation of nuclear localization in (<bold>A</bold>), dots represent individual animals. N = 2 biological replicates for L4 and N = 1 for day 4 adults, t-test, ns, not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66768-fig4-figsupp1-v1.tif"/></fig></fig-group><p>N-terminally tagged <italic>vha-13(syb586),</italic> however, was viable, showed expression that was regulated, and harbored two potential <italic>mir-1</italic> binding sites in the 3′UTR (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Moreover, <italic>vha-13</italic> RNAi (<italic>vha-13i</italic>) significantly compromised the motility of <italic>mir-1</italic>;Q35 strains in the RNAi screens (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), which we further confirmed through thrashing assays and the circle test (<xref ref-type="fig" rid="fig2">Figure 2E–G</xref>). <italic>vha-13i</italic> also significantly reduced pharyngeal pumping and life span in the <italic>mir-1</italic>;Q35 background compared to <italic>luci</italic> RNAi controls (<xref ref-type="fig" rid="fig2">Figure 2H, I</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a, b</xref>), yet had relatively minor effects on the motility of N2;Q35 itself (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>). We therefore focused on <italic>vha-13</italic> as a promising candidate to pursue in depth for regulatory interactions with miR-1.</p><p>We first characterized the expression pattern of <italic>vha-13(syb586[3xFlag::mNeonGreen::vha-13])</italic> in more detail. The <italic>3xFlag::mNeonGreen::vha-13</italic> was strongly expressed in the excretory cell, canal, hypodermis, as well as gut (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). In the hypodermis, 3xFlag::mNeonGreen::VHA-13 was localized in discrete foci (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). Notably, 3xFlag::mNeonGreen::VHA-13 also resided in miR-1-expressing tissues of body wall muscle, sex muscles, and pharynx, where it was more weakly expressed. Within muscle cells, VHA-13 localized to dense bodies (analogous to vertebrate Z disks) and intervening cytosol (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>).</p><p>Because <italic>mir-1</italic> is expressed in muscle tissues, we focused on quantifying the expression of <italic>vha-13</italic> in these tissues. Strikingly, we observed that <italic>vha-13</italic> levels were upregulated in the pharyngeal isthmus of <italic>mir-1(gk276)</italic> mutants (<xref ref-type="fig" rid="fig3">Figure 3C, D</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>), while conversely, overexpression of the <italic>mir-1</italic> transgene decreased levels in this tissue relative to WT (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>). To further investigate whether miR-1 directly regulates <italic>vha-13</italic>, we altered two predicted miR-1 binding sites (BS) in the 3′UTR (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). We first mutated miR-1 binding site 1 (<italic>vha-13</italic> BS1 [<italic>syb504</italic>], at position 188–195 of <italic>vha-13 3′UTR</italic>), and then additionally miR-1 binding site 2 (<italic>vha-13</italic> BS2 [<italic>syb2180</italic>], at position 253–258 of <italic>vha-13 3′UTR</italic>) in the endogenously tagged <italic>vha-13(syb586)</italic> strain. When only BS1 was mutated (MUT1), we still saw residual regulation of <italic>vha-13</italic> by miR-1 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>). Mutating both miR-1 binding sites (BS1,2: MUT2), however, de-repressed VHA-13 levels in the isthmus in the WT background (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). In double mutants containing both <italic>mir-1(gk276)</italic> and <italic>vha-13</italic> BS1,2 mutations, no clear regulation of <italic>vha-13</italic> expression was observed compared to the BS1,2 mutations alone (<xref ref-type="fig" rid="fig3">Figure 3G</xref>), suggesting that miR-1 modulates pharyngeal <italic>vha-13</italic> expression through both potential miR-1 binding sites.</p><p>We next sought to characterize <italic>vha-13</italic> regulation in the body wall muscle. However, it was not possible to accurately measure expression in this tissue using the <italic>3xFlag::mNeonGreen::vha-13</italic> strain due to the high expression levels in the adjacent hypodermis and gut. We therefore generated transgenic worms expressing Flag-tagged <italic>vha-13</italic> containing its endogenous 3′UTR (<italic>3xFlag::vha-13::vha-13 3′UTR</italic>) under control of the muscle-specific <italic>myo-3</italic> promoter. Consistent with results seen in pharyngeal muscle, <italic>vha-13</italic> protein levels in the body wall muscle were also upregulated in <italic>mir-1</italic> mutants compared to WT, as measured by western blots (<xref ref-type="fig" rid="fig3">Figure 3H, I</xref>). Exchanging the <italic>vha-13 3′UTR</italic> with the <italic>unc-54 3′UTR</italic> lacking miR-1 binding sites (<italic>vha-13::unc-54 3′UTR</italic>) blunted regulation by miR-1 (<xref ref-type="fig" rid="fig3">Figure 3F, I</xref>), indicating that <italic>vha-13</italic> is repressed by miR-1 via its 3′UTR in both body wall and pharyngeal muscle.</p><p>Since <italic>mir-1</italic> mutation resulted in <italic>vha-13</italic> upregulation, we asked whether <italic>vha-13</italic> overexpression was sufficient to yield phenotypes similar to <italic>mir-1</italic> mutants. In accord with this idea, overexpressing <italic>vha-13</italic> in the muscle of Q35 worms significantly reduced aggregate number, improved motility, and enhanced pharyngeal pumping ability (<xref ref-type="fig" rid="fig3">Figure 3J–L</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). It also significantly increased the life span of Q35 animals compared to non-transgenic controls in two out of five experiments (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). Altogether these data suggest that miR-1 and VHA-13 work in the same regulatory pathway to influence muscle physiology.</p><p>Since the regulation of <italic>vha-13</italic> by miR-1 was robust and functionally relevant in <italic>C. elegans</italic>, we wondered whether this regulation may be evolutionarily conserved. We analyzed v-ATPase expression in transcriptome data from previously published muscle-specific miR-1/miR-133a double knockout mice (<xref ref-type="bibr" rid="bib58">Wüst et al., 2018</xref>) and miR-1-1/miR-1-2 double knockout mice (<xref ref-type="bibr" rid="bib57">Wei et al., 2014</xref>). In muscle-specific miR-1/133a double knockout mice, <italic>Atp6v1a/vha-13</italic> and <italic>Atp6v1h/vha-15</italic> are significantly upregulated by 2.6-fold and 2.1-fold, respectively (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H</xref>). In miR-1-1/miR-1-2 double knockout mice, <italic>Atp6v1a/vha-13</italic> is significantly upregulated by 1.49-fold (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1I</xref>). These findings suggest that miR-1-dependent regulation of <italic>vha-13/Atp6v1a</italic> may be conserved during evolution.</p></sec><sec id="s2-4"><title>miR-1 affects lysosomal biogenesis</title><p>As the v-ATPase is an integral component of the lysosome, we asked whether miR-1 generally affects lysosomal structure and function. To test this idea, we first used a <italic>lmp-1p::lmp-1::gfp</italic> reporter strain. LMP-1 protein localizes to the membrane of lysosomes and is a marker for lysosomal biogenesis (<xref ref-type="bibr" rid="bib22">Hermann et al., 2005</xref>). LMP-1 protein levels were significantly increased in <italic>mir-1</italic> mutants compared to WT control, as measured by western blot analysis (<xref ref-type="fig" rid="fig4">Figure 4C, D</xref>). The v-ATPase hydrolyzes ATP to pump protons across the membrane, resulting in acidification of the lysosome lumen (<xref ref-type="bibr" rid="bib3">Beyenbach and Wieczorek, 2006</xref>). We therefore asked whether <italic>mir-1</italic> mutants affect the number of acidified lysosomes. Using Lysotracker Red, a dye that targets acidic membranous structures such as lysosomes (<xref ref-type="bibr" rid="bib7">Chazotte, 2011</xref>), we observed an increase in the number of acidified puncta in <italic>mir-1</italic> mutants at day 4 of adulthood (<xref ref-type="fig" rid="fig4">Figure 4E, F</xref>). Due to technical limitations, lysotracker staining could only be observed in the worm intestine. This result leaves open the question as to whether lysosomes are also regulated in the muscle and whether <italic>mir-1</italic>, being expressed in muscle tissue, might have a cell non-autonomous effect. Nonetheless, the overall increase in lysosome biogenesis is consistent with the upregulation of lysosomal components, such as the v-ATPase subunits, and a possible cause of miR-1-dependent regulation of proteostasis.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Striated muscle is one of the most highly ordered tissues in the body, with molecular components organized in a lattice of contractile elements and attachments. This molecular apparatus is exposed to high energy and force during contraction, inflicting molecular damage requiring constant repair. Further, muscle is subject to growth, metabolic, and stress signaling pathways as well as neural inputs that also promote remodeling. Underlying muscle plasticity is the fine-tuned control of proteostasis, including protein synthesis, folding, trafficking, and turnover, which must be precisely orchestrated to maintain muscle structure and function (<xref ref-type="bibr" rid="bib13">Demontis et al., 2013</xref>). A decline in these processes during aging leads to diminished muscle performance and frailty, yet it remains elusive how various aspects of muscle proteostasis are coordinated.</p><p>In this work, we discovered that the muscle-enriched microRNA miR-1 plays an important role in regulating muscle homeostasis via vacuolar ATPase function. Loss of <italic>mir-1</italic> ameliorates age-related decline in motility induced by models of aggregate-prone polyQ35. By inference, <italic>mir-1</italic> normally limits the proteoprotective effect in the polyQ35 model. Computational and proteomic screens identified v-ATPase subunits as highly enriched targets of miR-1 regulation, suggestive of coordinate regulation, and whose downregulation reduced polyQ35 proteoprotection. Expression studies confirmed that several subunits (e.g., <italic>vha-5, vha-10, vha-13, vha-19</italic>) showed miR-1-dependent regulation. In particular, we demonstrated that <italic>vha-13</italic> expression is downregulated by miR-1 in muscle tissues via two distinct binding sites in its 3′UTR. Moreover, VHA-13 links miR-1 with muscle homeostasis since <italic>vha-13</italic> downregulation abolished the improved mid-life motility, pharyngeal pumping, and life span of <italic>mir-1</italic>;Q35 strains, while <italic>vha-13</italic> overexpression was sufficient to enhance these properties, similar to <italic>mir-1</italic> mutation. In accord with our findings, immunoprecipitation and sequencing of microRNA complexes revealed a number of v-ATPase subunit mRNAs, including <italic>vha-13</italic>, <italic>vha-4, vha-10,</italic> and <italic>vha-17</italic> as physically associated with <italic>C. elegans</italic> miR-1 (<xref ref-type="bibr" rid="bib19">Grosswendt et al., 2014</xref>). Interestingly, mammalian homolog of VHA-13, ATP6V1A, as well as several other v-ATPase subunits, harbor predicted miR-1 binding sites (<xref ref-type="bibr" rid="bib53">Stark et al., 2005</xref>). Transcriptome data from mice indicate that <italic>Atp6v1a</italic> is upregulated upon miR-1-1/miR-1–2 deletion or miR-1/miR-133a deletion (<xref ref-type="bibr" rid="bib57">Wei et al., 2014</xref>; <xref ref-type="bibr" rid="bib58">Wüst et al., 2018</xref>). These findings complement our results in <italic>C. elegans</italic> and suggest that the miR-1-ATP6V1A regulatory module could be conserved in evolution.</p><p>The v-ATPase is a multisubunit enzyme that acidifies the endolysosomal lumen to control a plethora of cellular activities. Acidification regulates protein trafficking, endocytic recycling, synaptic vesicle loading, and autophagy, as well as the activity of multiple acid hydrolases and nutrient and ion transporters. Moreover, the v-ATPase itself serves as a docking site for regulating mTOR and AMPK complexes and affects metabolism (<xref ref-type="bibr" rid="bib50">Settembre et al., 2013</xref>; <xref ref-type="bibr" rid="bib60">Zhang et al., 2014</xref>). Our studies highlight the importance of v-ATPase activity to muscle performance. A handful of studies ascribe a role for the v-ATPase in muscle. In mammalian cardiomyocytes, lipid loading inhibits the v-ATPase, leading to a decline in contractile function that could contribute to muscle deficits in diabetes (<xref ref-type="bibr" rid="bib55">Wang et al., 2020</xref>). Lesions in VMA21 that disrupt v-ATPase assembly have also been shown to cause myopathies (<xref ref-type="bibr" rid="bib15">Dowling et al., 2015</xref>). Conceivably the v-ATPase could play an important role in protein turnover and remodeling of muscle structure but could also impact muscle homeostasis through metabolic wiring or protein trafficking.</p><p>Surprisingly we also found that some <italic>mir-1</italic> phenotypes were not strictly limited to muscle since we observed a global increase in levels of lysosomal LMP-1::GFP in western blots, increased lysosomal acidification in the intestine, as well as enhanced nuclear localization of HLH-30/TFEB in the hypodermis. Given that <italic>mir-1</italic> is muscle-expressed, this observation could suggest cell non-autonomous regulation of lysosomal biogenesis and associated activities by miR-1, acting either directly or indirectly. Conceivably, miR-1 is secreted from muscle to affect physiology in other tissues. In mammals, miR-1 has been identified as a circulating microRNA found in serum exosomes upon exercise stress or cardiac infarction, suggesting that it could act systemically (<xref ref-type="bibr" rid="bib9">Cheng et al., 2019</xref>; <xref ref-type="bibr" rid="bib16">D’Souza et al., 2018</xref>). In this light, it is intriguing that the v-ATPase itself is implicated in exosomal activity (<xref ref-type="bibr" rid="bib31">Liégeois et al., 2006</xref>). Alternately, miR-1 could act indirectly through production of a myokine that affects distal tissues.</p><p>miR-1 has been implicated in regulating a number of targets and physiologic processes. In mammals, miR-1 and its homolog miR<italic>-</italic>133 are essential to cardiac development and function, where they have been shown to regulate Notch ligand Dll1, the GTPase dynamin 2 (DNM2), Frizzled-7 (FZD7), and fibroblast growth factor receptor substrate 2 (FRS2) as targets (<xref ref-type="bibr" rid="bib26">Ivey et al., 2008</xref>; <xref ref-type="bibr" rid="bib33">Liu et al., 2011</xref>; <xref ref-type="bibr" rid="bib38">Mitchelson and Qin, 2015</xref>). Surprisingly knockout of mammalian <italic>mir1/mir133</italic> specifically in muscle has little overt effect on muscle structure, but rather regulates the developmental transition from glycolytic to oxidative metabolism via the Mef2/Dlk1-Dio3 axis, affecting running endurance (<xref ref-type="bibr" rid="bib58">Wüst et al., 2018</xref>). Similarly, <italic>C. elegans</italic> miR-1 regulates <italic>mef-2</italic>, in this case affecting retrograde signaling at the neuromuscular junction (<xref ref-type="bibr" rid="bib51">Simon et al., 2008</xref>). We also observed that animals lacking <italic>mir-1</italic> have little overt change in muscle structure or function alone, though we saw upregulation of a number of muscle proteins and downregulation of mitochondrial proteins in our proteomic analysis. Indeed, most microRNA knockouts do not lead to observable phenotypes in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib37">Miska et al., 2007</xref>), suggesting that microRNAs often work redundantly or in response to stress to fine-tune gene expression.</p><p>We identified <italic>mir-1</italic> as a suppressor of the muscle-specific polyQ35 proteotoxicity model, reducing protein aggregation and having beneficial effects on late-life motility, pumping rates (day 8 of adulthood), and life span. Recently, Pocock and colleagues reported that miR-1 downregulates the Rab GTPase TBC-7/TBC1D15, thereby promoting autophagic flux in worms and human cells (<xref ref-type="bibr" rid="bib41">Nehammer et al., 2019</xref>). In <italic>C. elegans,</italic> they observed that <italic>mir-1(+)</italic> ameliorates polyQ40 proteotoxicity, seemingly contradicting our results. We found <italic>mir-1</italic> deletion to reduce aggregate numbers in polyQ35, polyQ40, and α-syn models, while effects on motility varied among the three models. The relationship between aggregation and cellular toxicity remains controversial, and the uncoupling of aggregation and toxicity is observed in various disease models. Mammalian studies suggest context-dependent <italic>mir-1</italic> effects, where <italic>mir-1</italic> either promotes or inhibits autophagy (<xref ref-type="bibr" rid="bib17">Ejlerskov et al., 2020</xref>; <xref ref-type="bibr" rid="bib24">Hua et al., 2018</xref>; <xref ref-type="bibr" rid="bib59">Xu et al., 2020</xref>). Whether miR-1 is proteoprotective or limits proteoprotection in <italic>C. elegans</italic> could hinge on many factors. Because microRNAs generally fine-tune regulation and often work in feedback circuits, their impact on physiology can be subtle, and small differences in culture conditions, genetic background, metabolic state, and aggregation onset during development or aging could give rise to divergent outcomes.</p><p>Among the putative miR-1 targets that we identified in <italic>C. elegans</italic> are the pro-longevity transcription factors DAF-16/FOXO and HLH-30/TFEB, which regulate lysosome biogenesis, proteostasis, and metabolism, and act in insulin/IGF and mTOR signaling pathways (<xref ref-type="bibr" rid="bib32">Lin et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">O'Rourke and Ruvkun, 2013</xref>; <xref ref-type="bibr" rid="bib49">Settembre et al., 2011</xref>). <italic>mir-1</italic> mutation led to an upregulation of their mRNA during adulthood and enhanced nuclear localization of HLH-30. Further RNAi knockdown of these factors modestly diminished the motility improvement of <italic>mir-1</italic> mutants in the circle test, consistent with roles in a miR-1 signaling pathway. Whether these transcription factors are direct targets of miR-1 regulation remains to be seen. Notably, miR-1-predicted targets also include pro-aging components of mTOR signaling such as <italic>let-363/</italic>mTOR and <italic>raga-1/</italic>RagA (<ext-link ext-link-type="uri" xlink:href="http://www.targetscan.org/vert_72/">targetscan.org</ext-link>), which also regulate the activity or localization of these transcription factors. Hence, the balance or timing of pro- and anti-aging factors could also differentially influence the physiological phenotype at a systemic level. Interestingly, VHA-13/ATP6V1A subunit has been shown to regulate mTOR lysosomal recruitment and activity (<xref ref-type="bibr" rid="bib10">Chung et al., 2019</xref>) and mTOR signaling regulates the activity of TFEB at the lysosomal surface (<xref ref-type="bibr" rid="bib50">Settembre et al., 2013</xref>). Upregulation of v-ATPase activity is also associated with the clearance of oxidized protein and rejuvenation of the <italic>C. elegans</italic> germline (<xref ref-type="bibr" rid="bib4">Bohnert and Kenyon, 2017</xref>). Thus, in the future it will be interesting to further unravel the miR-1 molecular circuitry surrounding lysosomal function and proteostasis, and see whether miR-1 similarly regulates v-ATPase function in humans.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or <break/>resource</th><th valign="top">Designation</th><th valign="top">Source or <break/>reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Gene (<italic>Caenorhabditis elegans</italic>)</td><td valign="top"> <italic>mir-1</italic></td><td valign="top">WormBase</td><td valign="top">WBGene00003260</td><td valign="top"/></tr><tr><td valign="top">Gene (<italic>Caenorhabditis elegans</italic>)</td><td valign="top"> <italic>vha-13</italic></td><td valign="top">WormBase</td><td valign="top">WBGene00013025</td><td valign="top"/></tr><tr><td valign="top">Gene (<italic>Caenorhabditis elegans</italic>)</td><td valign="top"> <italic>vha-5</italic></td><td valign="top">WormBase</td><td valign="top">WBGene00006914</td><td valign="top"/></tr><tr><td valign="top">Gene (<italic>Caenorhabditis elegans</italic>)</td><td valign="top"> <italic>hlh-30</italic></td><td valign="top">WormBase</td><td valign="top">WBGene00020930</td><td valign="top"/></tr><tr><td valign="top">Gene (<italic>Caenorhabditis elegans</italic>)</td><td valign="top"> <italic>daf-16</italic></td><td valign="top">WormBase</td><td valign="top">WBGene00000912</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top">N2 Bristol</td><td valign="top">CGC</td><td valign="top">N2 Bristol <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/WB-STRAIN:WBStrain00000001">WB-STRAIN:WBStrain00000001</ext-link></td><td valign="top">N2 <break/>WT</td></tr><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I</td><td valign="top">This paper</td><td valign="top">AA2508 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/WB-STRAIN:WBStrain00035886">WB-STRAIN:WBStrain00035886</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(dh1111)</italic> I</td><td valign="top">This paper</td><td valign="top">AA4575</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>rmIs132[unc-54p::Q35::YFP]</italic> I</td><td valign="top">CGC</td><td valign="top">AM140 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/WB-STRAIN:WBStrain00000182">WB-STRAIN:WBStrain00000182</ext-link></td><td valign="top">N2;Q35</td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276); rmIs132[unc-54p::Q35::YFP]</italic> I</td><td valign="top">This paper</td><td valign="top">AA4403</td><td valign="top"><italic>gk276</italic>;Q35</td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(dh1111) rmIs132[unc-54p::Q35::YFP]</italic> I</td><td valign="top">This paper</td><td valign="top">AA4577</td><td valign="top"><italic>dh1111</italic>;Q35</td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top">N2; <italic>dhEx965[mir-1p::mir-1, myo-2p::mCherry]</italic></td><td valign="top">This paper</td><td valign="top">AA3275</td><td valign="top"><italic>mir-1</italic> transgene</td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I<italic>; rmIs132[unc-54p::Q35::YFP]; dhEx965[mir-1p::mir-1, myo-2p::mCherry]</italic></td><td valign="top">This paper</td><td valign="top">AA4810</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top">N2; <italic>dhEx1206[myo3p::flag::HA::mCherry::vha-13cDNA::unc-54</italic> 3′UTR<italic>, myo-2p::GFP]</italic></td><td valign="top">This paper</td><td valign="top">AA4865</td><td valign="top"><italic>myo3p::vha-13::unc-54 3′UTR</italic></td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I<italic>; dhEx1206[myo-3p::flag::HA::mCherry::vha-13cDNA::unc-54</italic> 3<italic>′</italic>UTR<italic>, myo-2p::GFP]</italic></td><td valign="top">This paper</td><td valign="top">AA4866</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top">N2; <italic>dhEx1207[myo-3p::flag::HA::mCherry::vha-13cDNA::vha-13</italic> 3′UTR<italic>, myo-2p::GFP]</italic></td><td valign="top">This paper</td><td valign="top">AA5067</td><td valign="top"><italic>myo-3p::vha-13 wt 3′UTR</italic></td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I<italic>; dhEx1207[myo-3p::flag::HA::mCherry::vha-13cDNA::vha-13</italic> 3′UTR<italic>, myo-2p::GFP]</italic></td><td valign="top">This paper</td><td valign="top">AA5068</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>vha-13(syb586[3xFlag::mNeonGreen::vha-13])</italic> V</td><td valign="top">SunyBiotech</td><td valign="top">PHX586</td><td valign="top"><italic>vha-13 wt 3′UTR</italic></td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I; <italic>vha-13(syb586[3xFlag::mNeonGreen::vha-13]) </italic>V</td><td valign="top">This paper</td><td valign="top">AA4813</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>vha-13(syb586[3xFlag::mNeonGreen::vha-13])</italic> V; <italic>dhEx965[mir-1p::mir-1, myo-2p::mCherry]</italic></td><td valign="top">This paper</td><td valign="top">AA4850</td><td valign="top"><italic>vha-13 wt 3′UTR + mir-1</italic> transgene</td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>vha-13(syb587,syb504[3xFlag::mNeonGreen::vha-13</italic> miR-1 BS1 mutated]) V</td><td valign="top">SunyBiotech</td><td valign="top">PHX587</td><td valign="top"><italic>vha-13 MUT1 3′UTR</italic> <break/>One <italic>miR-1</italic> BS mutated</td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I; <italic>vha-13(syb587,syb504[3xFlag::mNeonGreen::vha-13</italic> miR-1 BS1 mutated]) V</td><td valign="top">This paper</td><td valign="top">AA4184</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>vha-13(syb2180,syb587,syb504[3xFlag::mNeonGreen::vha-13</italic> miR-1 BS1,2 mutated]) V</td><td valign="top">SunyBiotech</td><td valign="top">PHX2180</td><td valign="top"><italic>vha-13 MUT2 3′UTR</italic> <break/>Two <italic>miR-1</italic> BSs mutated</td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I; <italic>vha-13(syb2180,syb587,syb504[3xFlag::mNeonGreen::vha-13</italic> miR-1 BS,2 mutated]) V</td><td valign="top">This paper</td><td valign="top">AA5123</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>vha-5(syb1093[3xFlag::mNeonGreen::vha-5])</italic> IV</td><td valign="top">SunyBiotech</td><td valign="top">PHX1093</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis</italic> <break/><italic>elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I; <italic>vha-5(syb1093[3xFlag::mNeonGreen::vha-5])</italic> IV</td><td valign="top">This paper</td><td valign="top">AA5069</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>hlh-30(syb809[hlh-30::mNeonGreen])</italic> IV</td><td valign="top">SunyBiotech</td><td valign="top">PHX809</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I; <italic>hlh-30(syb809[hlh-30::mNeonGreen])</italic> IV</td><td valign="top">This paper</td><td valign="top">AA5195</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>rmIs133[P(unc-54) Q40::YFP]</italic></td><td valign="top">CGC</td><td valign="top">AM141 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/WB-STRAIN:WBStrain00000183">WB-STRAIN:WBStrain00000183</ext-link></td><td valign="top">N2;Q40</td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I; <italic>rmIs133[P(unc-54) Q40::YFP]</italic></td><td valign="top">This paper</td><td valign="top">AA3112</td><td valign="top"><italic>gk276</italic>;Q40</td></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top">N2; <italic>pkIs2386[Punc-54::alphasynuclein::YFP + unc-119(+)]</italic></td><td valign="top">This paper</td><td valign="top">AA1311</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Caenorhabditis elegans</italic>)</td><td valign="top"><italic>mir-1(gk276)</italic> I; <italic>pkIs2386[Punc-54::alphasynuclein::YFP + unc-119(+)]</italic></td><td valign="top">This paper</td><td valign="top">AA5270</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Escherichia coli</italic>)</td><td valign="top">OP50</td><td valign="top">CGC</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain background <break/>(<italic>Escherichia coli</italic>)</td><td valign="top">DH5α</td><td valign="top">Life Technologies</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">RNAi</td><td valign="top">Source BioScience, <italic>C. elegans</italic> RNAi Collection – Ahringer</td><td valign="top">Multiple</td><td valign="top"><xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref></td></tr><tr><td valign="top">Other</td><td valign="top">RNAi</td><td valign="top">Source BioScience, <break/><italic>C. elegans</italic> ORF-RNAi Resource – Vidal</td><td valign="top">Multiple</td><td valign="top"><xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref></td></tr><tr><td valign="top">Other</td><td valign="top"><italic>hlh-30</italic> RNAi</td><td valign="top">Source BioScience, <italic>C. elegans</italic> RNAi Collection – Ahringer</td><td valign="top">W02C12.3</td><td valign="top"><italic>hlh-30i</italic></td></tr><tr><td valign="top">Other</td><td valign="top"><italic>daf-16</italic> RNAi</td><td valign="top">Source BioScience, <italic>C. elegans</italic> RNAi Collection – Ahringer</td><td valign="top">R13H8.1</td><td valign="top"><italic>daf-16i</italic></td></tr><tr><td valign="top">Other</td><td valign="top"><italic>vha-13</italic> RNAi</td><td valign="top">Source BioScience, <italic>C. elegans</italic> RNAi Collection – Ahringer</td><td valign="top">Y49A3A.2</td><td valign="top"><italic>vha-13i</italic></td></tr><tr><td valign="top">Other</td><td valign="top"><italic>vha-5</italic> RNAi</td><td valign="top">Source BioScience, <italic>C. elegans</italic> RNAi Collection – Ahringer</td><td valign="top">F35H10.4</td><td valign="top"><italic>vha-5i</italic></td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid L3781</td><td valign="top">FireLab</td><td valign="top"/><td valign="top">Worm Expression vector</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid pDEST R4-R3</td><td valign="top">Invitrogen</td><td valign="top"/><td valign="top">MultiSite Gateway destination vector</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid <italic>myo3p::flag::HA::mCherry::vha-13cDNA::unc-54</italic> 3′UTR</td><td valign="top">This paper</td><td valign="top">BA4331</td><td valign="top">Vector pDEST R4-R3</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid <italic>myo3p::flag::HA::mCherry::vha-13cDNA::vha-13</italic> 3′UTR</td><td valign="top">This paper</td><td valign="top">BA4334</td><td valign="top">Vector pDEST R4-R3</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid pPD122.11</td><td valign="top">FireLab</td><td valign="top"/><td valign="top">Worm Expression vector</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Primer</td><td valign="top">This paper</td><td valign="top"/><td valign="top"><xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref></td></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">TaqMan assay for mir-1</td><td valign="top">Life Technologies</td><td valign="top">Assay ID 000385</td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-GFP <break/>(mouse monoclonal)</td><td valign="top">Living Colors</td><td valign="top">JL-8 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10013427">AB_10013427</ext-link></td><td valign="top">1:2000</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Histone H3 (rabbit polyclonal)</td><td valign="top">Abcam</td><td valign="top">ab1791 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_302613">AB_302613</ext-link></td><td valign="top">1:5000</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-α-Tubulin (mouse monoclonal)</td><td valign="top">Sigma</td><td valign="top">T6199 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_477583">AB_477583</ext-link></td><td valign="top">1:5000</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-FLAG (mouse monoclonal)</td><td valign="top">Sigma</td><td valign="top">F1804 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_262044">AB_262044</ext-link></td><td valign="top">1:2000</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-mouse IgG (goat polyclonal coupled with horseradish peroxidase)</td><td valign="top">Invitrogen</td><td valign="top">G-21040 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2536527">AB_2536527</ext-link></td><td valign="top">1:5000</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-rabbit IgG (goat polyclonal coupled with horseradish peroxidase)</td><td valign="top">Invitrogen</td><td valign="top">G-21234 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2536530">AB_2536530</ext-link></td><td valign="top">1:5000</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">LysoTracker Red</td><td valign="top">Life Technologies</td><td valign="top">LysoTracker Red DND-99</td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title><italic>C. elegans</italic> strains and culture</title><p><italic>C. elegans</italic> strains were maintained at 20°C on nematode growth medium (NGM) plates seeded with a lawn of <italic>Escherichia coli</italic> strain OP50, unless noted otherwise. Strains are listed in the Key resources table.</p></sec><sec id="s4-2"><title>Molecular cloning</title><p>All restriction digest reactions were performed with enzymes provided by NEB according to the user's manual. T4 DNA Ligase (NEB) was used for ligation reactions. Chemically competent DH5α <italic>E. coli</italic> (Life Technologies) was used for transformation following the manufacturer’s instructions. QIAprep Miniprep or Midiprep Kits (Qiagen) were used for plasmid purification. Cloning was verified by PCR followed by gel electrophoresis and sequencing.</p><p>To make the rescuing <italic>mir-1</italic> transgene, primer pair ‘celmir1fwd2/rvs2’ was used to insert the <italic>mir-1</italic> coding region into vector L3781 downstream of <italic>gfp</italic>. The <italic>mir-1</italic> promoter was then cloned 5' to <italic>gfp</italic> using the primer pair ‘m1p fwd/rvs’. To make muscle-expressed <italic>vha-13</italic> constructs, the <italic>vha-13</italic> cDNA was amplified with Kpn1 overhangs using primers vha-13 fwd/rvs and cloned into vector pDEST R4-R3 to give <italic>myo-3p::flag::HA::mCherry::vha-13cDNA::unc-54</italic> 3'UTR. The <italic>unc-54</italic> 3'UTR was excised with Not1/BglI and replaced with the <italic>vha-13</italic> 3'UTR using primers vha-13U fwd/rvs to generate <italic>myo-3p::flag::HA::mCherry::vha-13cDNA::vha-13</italic> 3'UTR. Primers and plasmids are listed in the Key resources table and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>.</p></sec><sec id="s4-3"><title>Generation of transgenic worm strains</title><p>Transgenic worms containing extrachromosomal arrays were generated by microinjection. To generate the <italic>myo-3p::flag::HA::mCherry::vha-13cDNA::unc-54</italic> 3'UTR strain, a mix of <italic>myo-3p::flag::HA::mCherry::vha-13cDNA::unc-54</italic> 3'UTR DNA (40 ng/ μl), <italic>myo-2p::gfp</italic> co-transformation marker (5 ng/ μl plasmid pPD122.11), and fill DNA (TOPO empty vector, 55 ng/μl) was injected into young N2 adults using an Axio Imager Z1 microscope (Zeiss) with a manual micromanipulator (Narishige) connected to a microinjector (FemtoJet 4x, Eppendorf). We obtained the strain AA4865: N2<italic>; dhEx1206[myo-3p::flag::HA::mCherry::vha-13cDNA::unc-54</italic> 3'UTR<italic>, myo-2p::gfp]</italic>, which was then used to cross the transgene into other genetic backgrounds. A similar strategy was used to create AA5067, N2; dh<italic>Ex1207[myo-3p::flag::HA::mCherry::vha-13cDNA::vha-13</italic> 3'UTR<italic>, myo-2p::GFP].</italic></p><p>The <italic>mir-1</italic> transgene strain was generated by injection mix containing <italic>mir-1p::mir-1</italic> plasmid, <italic>myo-2p::mCherry</italic> co-transformation marker (5 ng/μl plasmid pPD122.11) and fill DNA (L3781 empty vector). The resultant strain AA3275 (N2; <italic>dhEx965[mir-1p::mir-1, myo-2p::mCherry]</italic>) was then used to cross the <italic>dhEx965</italic> transgene to <italic>mir-1(gk276); rmIs132[p(unc-54) Q35::YFP]</italic> to give <italic>mir-1(gk276); rmIs132[p(unc-54) Q35::YFP]; dhEx965[mir-1p::mir-1, myo-2p::mCherry]</italic>, AA4810. For transgenic worm strains, non-transgenic worms of the same strain were used as controls.</p><p>The <italic>mir-1</italic> deletion allele <italic>dh1111</italic> was generated using CRISPR/Cas9 mutagenesis. We designed CRISPR guides using the EnGen sgRNA Designer (<ext-link ext-link-type="uri" xlink:href="https://sgrna.neb.com/#!/sgrna">https://sgrna.neb.com/#!/sgrna</ext-link>), synthesized guides with the Engen sgRNA synthesis kit and analyzed them by gel electrophoresis and tape station. We injected worms with an injection mix containing Cas9 EnGen (NEB), four sgRNAs against <italic>mir-1</italic> (<named-content content-type="sequence">AAGAAGTATGTAGAACGGGG</named-content>, <named-content content-type="sequence">GTAAAGAAGTATGTAGAACG</named-content>, <named-content content-type="sequence">TATAGAGTAGAATTGAATCT</named-content>, <named-content content-type="sequence">ATATAGAGTAGAATTGAATC</named-content>), one sgRNA against <italic>dpy-10</italic> (<named-content content-type="sequence">CGCTACCATAGGCACCACG</named-content>), KCl, HEPES pH 7.4, and water. Prior to injection we incubated the mixture for 10 min at 37°C to allow activation of Cas9. Following injection, we singled out worms with Dpy and Rol phenotypes in the F1 generation and genotyped them for <italic>mir-1</italic> deletion using <italic>mir-1</italic> genotyping primers in the F2 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>). We sequenced the PCR products of candidate worms with Sanger sequencing and verified that the deletions resulted in loss of <italic>mir-1</italic> expression using TaqMan-based quantification of mature miRNA levels.</p><p>Endogenous fluorescently tagged strains were generated by tagging <italic>vha-5</italic> or <italic>vha-13</italic> with 3xFlag-mNeonGreen tag at the N-terminus using CRISPR–Cas9 (SunyBiotech). The <italic>vha-13</italic> 3'UTR mutants BS1 and BS2 were generated using CRISPR–Cas9 by further mutating one or both putative miR-1 binding sites in the 3'UTR of the endogenous FLAG-mNeonGreen-tagged <italic>vha-13 gene</italic> (SunyBiotech). PHX809 <italic>hlh-30::mNeonGreen</italic> endogenously tagged <italic>hlh-30</italic> was generated by placing <italic>mNeonGreen</italic> at the C-terminus using CRISPR–Cas9 (SunyBiotech).</p></sec><sec id="s4-4"><title>Determination of progeny number</title><p>Single worms were maintained on an NGM agar plate and transferred every day until the reproductive period was complete. The number of F1 progeny per individual worm was counted at the L4 or young adult stage. Experiments were repeated at least three times.</p></sec><sec id="s4-5"><title>Quantitation of polyQ and α-synuclein aggregates</title><p>Whole-worm images of day 4 adults (Q34), L4s (Q40), or day 1 adults (α-synuclein) were taken with an Axiocam 506 mono (Zeiss) camera using the 5×, 10×, or 20× objective of a Zeiss Axio Imager Z1 microscope at defined exposure time (Q35: 20 ms, Q40: 10 ms, α-synuclein: 10 ms). Aggregate numbers were evaluated from the photos. Due to the smaller size and relatively lower number of aggregates in the α-synuclein model, a maximum intensity projection was created from a Z-stack of the head region and aggregates present from the nose tip to the posterior bulb were counted. Genotypes of the samples were blinded during the counting. Aggregates were defined as discrete structures or puncta above background.</p></sec><sec id="s4-6"><title>Motility, thrashing, and pumping behavior</title><p>To analyze worm motility by the circle test, 20–25 worms of defined age (day 3 to day 14 of adulthood) were placed in the center of a 6 cm agar plate with bacteria, marked with 1 cm circle on the bottom. After a defined time period (1 or 30 min), the number of worms that left the circle was counted. To determine thrashing rate, individual worms were transferred to M9 buffer and the number of body bends in a 20–60 s interval was scored. Pharyngeal pumping rates were measured by counting grinder contraction in the terminal bulb in 20–30 s intervals. Genotypes were blinded during the experiments.</p></sec><sec id="s4-7"><title>CeleST assay</title><p>The <italic>C. elegans</italic> Swim Test (CeleST) assay was used to assess animal motility while swimming; assays were conducted as described previously (<xref ref-type="bibr" rid="bib25">Ibáñez-Ventoso et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Restif et al., 2014</xref>). Four or five animals were picked and placed into the swimming arena, which was a 50 μl aliquot of M9 buffer inside a 10 mm pre-printed ring on the surface of a glass microscope slide (Thermo Fisher Scientific). Images of the animals within the swim arena were acquired with a LEICA MDG41 microscope at 1× magnification with a Leica DFC3000G camera. Image sequences of 30 s in duration were captured at a rate of ~16 frames per second. The established CeleST software was used to process the image sequences and extract eight measures that are descriptive of <italic>C. elegans</italic> swim motility. As not all images in a sequence are always successfully processed by the CeleST software, animals for which fewer than 80% of frames were valid were excluded from the analysis. For each measure, single measurements that did not fit within the range of normally observed values were deemed outliers and also excluded from the analysis. Unpaired Student’s t-test was used to test for statistical significance between two strains at adult days 4 and 8.</p></sec><sec id="s4-8"><title>Life span and heat stress experiments</title><p>Life span experiments were performed as described (<xref ref-type="bibr" rid="bib18">Gerisch et al., 2007</xref>). Day 0 corresponds to the L4 stage. Life spans were determined by scoring a population of 100–120 worms per genotype every day or every other day. Worms that exploded, had internal hatch, or left the plate were censored. Heat stress experiments were performed at 35°C (<xref ref-type="bibr" rid="bib18">Gerisch et al., 2007</xref>). Day 1 adult worms were transferred onto pre-heated (35°C) plates 6 cm plates seeded with OP50. Worms were kept at 35°C and scored every hour for live versus dead. Experiments were repeated at least three times. Data were analyzed with Microsoft Excel and GraphPad Prism Software. p values were calculated using the Log-rank (Mantel–Cox) test to compare two independent populations.</p></sec><sec id="s4-9"><title>RNAi treatment</title><p>Worms were grown from L4 onwards unless mentioned otherwise on <italic>E. coli</italic> HT115 (DE3) bacteria expressing dsRNA of the target gene under the control of an IPTG-inducible promoter. RNAi colonies were grown overnight at 37°C in Luria Broth with 50 μg/ml ampicillin and 10 μg/ml tetracycline. The cultures were spun down at 4000 rpm at 4°C for 10 min. 500 μl of onefold concentrated culture was seeded onto NGM plates containing 1 M isopropyl β-D-1-thiogalactopyranoside (IPTG) to induce dsRNA expression. RNAi clones were selected from the Ahringer or Vidal library (<xref ref-type="bibr" rid="bib29">Kamath and Ahringer, 2003</xref>; <xref ref-type="bibr" rid="bib47">Rual et al., 2004</xref>). Clone identity was confirmed by sequencing.</p></sec><sec id="s4-10"><title>RNAi screen for <italic>mir-1</italic> suppressors</title><p><italic>mir-1(gk276);</italic>Q35 worms were grown from L4 on RNAi of the candidates identified in the bioinformatic or proteomic screen. Worms were maintained in the presence of FUDR (40 μM 5-fluoro-2′-deoxyuridine, Sigma) until day 8 of adulthood. The circle test was performed as described above. The number of worms that left the circle was determined after 1 min. Selected candidates identified in the circle test were examined in the body bending assay (see above). The effect of selected candidate RNAi clones was additionally tested on polyQ35 in the WT background as counter screen. For this experiment, worms were grown until day 5 of adulthood. Motility assays were performed on day 5 of adulthood because Q35 WT worms were less motile than the <italic>mir-1(gk276)</italic>;Q35 and were largely paralyzed by day 8.</p></sec><sec id="s4-11"><title>RNA extraction and real-time qPCR analysis</title><p>Worm populations (ca. 500 animals) were harvested on day 4 of adulthood and washed twice in cold M9. Worm pellets were taken up in 700 μl QIAzol reagent (Qiagen) and snap frozen in liquid nitrogen. Samples were subjected to four freeze/thaw cycles and homogenized with 1.0 mm zirconia/silica beads (Fisher Scientific) in a Tissue Lyser LT (Qiagen) for 15 min at full speed. After homogenization, 600 µl supernatant was transferred to fresh tubes and 120 μl chloroform were added to each tube. Components were mixed by vortexing and incubated for 2 min at room temperature. After 15 min centrifugation at 12,000 <italic>g</italic> 4°C, the aqueous phase was collected for total RNA extraction using the RNeasy or miRNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. RNA quantity and quality were determined on a NanoDrop 2000c (PeqLab RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_020309">SCR_020309</ext-link>) and cDNA was prepared using the iScript cDNA Synthesis Kit (BioRad). To quantify RNA expression, we used the Power SYBR Green Master Mix (Applied Biosystems) on a ViiA 7 Real-Time PCR system (Applied Biosystems). Four technical replicates were pipetted on a 384-well plate using the JANUS automated workstation (PerkinElmer). Expression of target RNA was calculated from comparative CT values, normalized to <italic>ama-1</italic> or <italic>cdc-42</italic> as internal controls using the corresponding ViiA7 software. All unpublished primers were validated by determination of their standard curves and melting properties. For quantification of <italic>mir-1,</italic> we used TaqMan probes from Life Technologies/Thermo Fisher Scientific (Assay ID 000385) and normalized to expression of U18 as measured by TaqMan probes from Life Technologies/Thermo Fisher Scientific (Assay ID 001764). We used N = 4 independent biological replicates, and four technical replicates for every biological sample (for primers, refer to <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>).</p></sec><sec id="s4-12"><title>Western blot analysis</title><p>For western blot analysis, synchronized young adult or gravid day 1 adult worms were picked into Eppendorf tubes containing M9, snap frozen in liquid nitrogen, and lysed in 4× SDS sample buffer (Thermo Fisher) containing 50 mM DTT. After boiling and sonication, equal volumes were subjected to reducing SDS-PAGE and transferred to nitrocellulose membranes. The membranes were then blocked for 2 hr at room temperature in 5% milk in Tris-buffered Saline and Tween20 (TBST) and probed with the primary antibodies in TBST with 5% milk overnight at 4°C. Specific secondary antibodies (mouse or rabbit) were used at a concentration of 1:5000 in TBST with 5% milk at room temperature for 2 hr. The membranes were developed with Western Lightening Plus – Enhanced Chemiluminescence Substrate (PerkinElmer). Bands were detected on a ChemiDoc MP Imaging System (BioRad) and the intensity quantified using the corresponding Image Lab software (BioRad). Antibodies are listed in the Key resources table.</p></sec><sec id="s4-13"><title>Proteomic analysis</title><p>For sample collection and preparation, day 1 N2 and <italic>mir-1(gk276)</italic> worms were synchronized by egg laying, and <italic>n</italic> ≥ 5000 worms per genotype were collected in M9. Samples were washed three times in M9 and directly frozen in liquid nitrogen and stored at –80°C. Five independent biological replicates of each genotype were collected for further analyses. For protein extraction, samples were thawed and boiled in lysis buffer (100 mM Tris-HCl, 6 M guanidinium chloride, 10 mM Tris(2-carboxyethyl)phosphine hydrochloride, 40 mM 2-chloroacetamide) for 10 min, lysed at high performance with a Bioruptor Plus sonicator (Diagenode) using 10 cycles of 30 s sonication intervals. The samples were then boiled again, centrifuged at 20,000 <italic>g</italic> for 20 min, and diluted 1:10 in 20 mM Tris pH 8.3/10% acetonitrile (ACN). Protein concentration was measured using BCA Protein Assays (Thermo Fisher). Samples were then digested overnight with rLys-C (Promega), the peptides were cleaned on a Supelco Visiprep SPE Vacuum Manifold (Sigma) using OASIS HLB Extraction cartridges (Waters). The columns were conditioned twice with methanol, equilibrated twice with 0.1% formic acid, loaded with the sample, washed three times with 0.1% formic acid, and the peptides eluted with 60% ACN/0.1% formic acid. The samples were dried at 30°C for roughly 4 hr in a Concentrator (Eppendorf) set for volatile aqueous substances. The dried peptides were taken up in 0.1% formic acid and the samples were analyzed by the Max Planck Proteomic Core facility. Mass spectrometry data acquisition, computational proteomic analysis, and differential expression analysis were performed as described (<xref ref-type="bibr" rid="bib54">Tharyan et al., 2020</xref>). Upon inspection of the numbers of quantified proteins and the raw proteomic data, two replicates of N2 were excluded from further analysis. Proteomics data was deposited to the ProteomeXchange Consortium via the PRIDE partner repository (<xref ref-type="bibr" rid="bib44">Perez-Riverol et al., 2019</xref>).</p></sec><sec id="s4-14"><title>Microscopy and expression analysis</title><p>For confocal microscopy, <italic>vha-13</italic>, <italic>vha-5,</italic> and <italic>hlh-30</italic> endogenously tagged with mNeonGreen were synchronized via egg and maintained at 25°C to induce mild stress. <italic>hlh-30</italic> worms were imaged as L4s and day 4 adults, while <italic>vha-13</italic> and <italic>vha-5</italic> worms as L4s, because of high mNeonGreen background expression at day 4 adulthood. Worms were anesthetized with 40 μM sodium azide, mounted on slide with 2% agar pad, and imaged with a Leica TCS SP8 microscope equipped with HC PL APO CS2 63×/1.40 oil and white light laser. Images were analyzed using Photoshop or Fiji software. To quantitate acidic lysosomes, worms grown at 25°C were incubated 48 hr prior to imaging with 2 μM LysoTracker Red DND-99 (Life Technologies). Worms were imaged as day 4 adults as described above. The number of puncta in a predefined squared area in the intestine (approximately spanning the second to fourth gut cell) was counted.</p></sec><sec id="s4-15"><title>Statistical analysis</title><p>The statistical tests performed in this study are indicated in the figure legends and in the Materials and methods. Data are represented as mean ± SEM or as individual data points, as stated in the figure legends. The number of replicates and animals for each experiment is enclosed in their respective figure legends.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>AA would like to thank the MPI-AGE proteomics and imaging cores for services, the Caenorhabditis Genetics Center (CGC, University of Minnesota) for worm strains, the Bundesministerium für Bildung und Forschung for Sybacol funding, the Deutscher Akademischer Austauschdienst for funding, and the Max Planck Gesellschaft for core institutional support. MAM would like to thank Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (grant number 2019/25958-9) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior CAPES (grant number 88881.143924/2017-01) for funding.</p> </ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Validation, Investigation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Data curation, Formal analysis, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Investigation, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Raw data.</title><p>(<bold>a</bold>) Life span and heat stress data. (<bold>b</bold>) Aggregate and behavior data. (<bold>c</bold>) CeleST data. (<bold>d</bold>) List of candidate genes with in silico predicted miR-1 binding sites using <ext-link ext-link-type="uri" xlink:href="http://microrna.org/">microRNA.org</ext-link>, TargetScanWorm, and PicTar. (<bold>e</bold>) RNAi motility screen. (<bold>f</bold>) Proteomic analysis of differentially regulated proteins in <italic>mir-1</italic> vs. wild-type. (<bold>g</bold>) Microscopy data. (<bold>h</bold>) Primers.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66768-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-66768-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (Perez-Riverol et al., 2019) with the dataset identifier PXD023544. All raw data underlying the figures are provided in the supplementary file.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Schiffer</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Data from: miR-1 coordinately regulates lysosomal v-ATPase and biogenesis to impact proteotoxicity and muscle function during aging</data-title><source>ProteomeXchange</source><pub-id assigning-authority="PDB" pub-id-type="accession" xlink:href="http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD023544">PXD023544</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Boettger</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Metabolic maturation during muscle stem cell differentiation is achieved by miR-1/133a-mediated inhibition of the Dlk-Dio3 mega gene cluster</data-title><source>ArrayExpress</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5936/?array=A-GEOD-17408">GEOD-17408</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>Identification of dysregulated genes after deletion of miR-1-1 and miR-1-2</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45760">GSE45760</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andachi</surname> <given-names>Y</given-names></name><name><surname>Kohara</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A whole-mount in situ hybridization method for microRNA detection in <italic>Caenorhabditis elegans</italic></article-title><source>RNA</source><volume>22</volume><fpage>1099</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.1261/rna.054239.115</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betel</surname> <given-names>D</given-names></name><name><surname>Wilson</surname> <given-names>M</given-names></name><name><surname>Gabow</surname> <given-names>A</given-names></name><name><surname>Marks</surname> <given-names>DS</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The microRNA.org resource: targets and expression</article-title><source>Nucleic Acids Research</source><volume>36</volume><fpage>D149</fpage><lpage>D153</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm995</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyenbach</surname> <given-names>KW</given-names></name><name><surname>Wieczorek</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The V-type H+ ATPase: molecular structure and function, physiological roles and regulation</article-title><source>Journal of Experimental Biology</source><volume>209</volume><fpage>577</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1242/jeb.02014</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohnert</surname> <given-names>KA</given-names></name><name><surname>Kenyon</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A lysosomal switch triggers proteostasis renewal in the immortal <italic>C. elegans</italic> germ lineage</article-title><source>Nature</source><volume>551</volume><fpage>629</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1038/nature24620</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brignull</surname> <given-names>HR</given-names></name><name><surname>Morley</surname> <given-names>JF</given-names></name><name><surname>Garcia</surname> <given-names>SM</given-names></name><name><surname>Morimoto</surname> <given-names>RI</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Modeling polyglutamine pathogenesis in <italic>C. elegans</italic></article-title><source>Methods in Enzymology</source><volume>412</volume><fpage>256</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(06)12016-9</pub-id><pub-id pub-id-type="pmid">17046663</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cartee</surname> <given-names>GD</given-names></name><name><surname>Hepple</surname> <given-names>RT</given-names></name><name><surname>Bamman</surname> <given-names>MM</given-names></name><name><surname>Zierath</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Exercise promotes healthy aging of skeletal muscle</article-title><source>Cell Metabolism</source><volume>23</volume><fpage>1034</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.05.007</pub-id><pub-id pub-id-type="pmid">27304505</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chazotte</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Labeling lysosomes in live cells with LysoTracker</article-title><source>Cold Spring Harbor Protocols</source><volume>2011</volume><elocation-id>prot5571</elocation-id><pub-id pub-id-type="doi">10.1101/pdb.prot5571</pub-id><pub-id pub-id-type="pmid">21285271</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Ba</surname> <given-names>Y</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Cai</surname> <given-names>X</given-names></name><name><surname>Yin</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>K</given-names></name><name><surname>Guo</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Xiang</surname> <given-names>Y</given-names></name><name><surname>Xu</surname> <given-names>C</given-names></name><name><surname>Zheng</surname> <given-names>P</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Shang</surname> <given-names>X</given-names></name><name><surname>Gong</surname> <given-names>T</given-names></name><name><surname>Ning</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Zen</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>C-Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases</article-title><source>Cell Research</source><volume>18</volume><fpage>997</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1038/cr.2008.282</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Zhao</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>E</given-names></name><name><surname>Zeng</surname> <given-names>Q</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Wu</surname> <given-names>B</given-names></name><name><surname>Yi</surname> <given-names>G</given-names></name><name><surname>Mao</surname> <given-names>X</given-names></name><name><surname>Huang</surname> <given-names>K</given-names></name><name><surname>Dong</surname> <given-names>N</given-names></name><name><surname>Xie</surname> <given-names>M</given-names></name><name><surname>Limdi</surname> <given-names>NA</given-names></name><name><surname>Prabhu</surname> <given-names>SD</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Qin</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>959</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-08895-7</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname> <given-names>CY-S</given-names></name><name><surname>Shin</surname> <given-names>HR</given-names></name><name><surname>Berdan</surname> <given-names>CA</given-names></name><name><surname>Ford</surname> <given-names>B</given-names></name><name><surname>Ward</surname> <given-names>CC</given-names></name><name><surname>Olzmann</surname> <given-names>JA</given-names></name><name><surname>Zoncu</surname> <given-names>R</given-names></name><name><surname>Nomura</surname> <given-names>DK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Covalent targeting of the vacuolar H+-ATPase activates autophagy via mTORC1 inhibition</article-title><source>Nature Chemical Biology</source><volume>15</volume><fpage>776</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1038/s41589-019-0308-4</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>E</given-names></name><name><surname>Bieschke</surname> <given-names>J</given-names></name><name><surname>Perciavalle</surname> <given-names>RM</given-names></name><name><surname>Kelly</surname> <given-names>JW</given-names></name><name><surname>Dillin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Opposing activities protect against age-onset proteotoxicity</article-title><source>Science</source><volume>313</volume><fpage>1604</fpage><lpage>1610</lpage><pub-id pub-id-type="doi">10.1126/science.1124646</pub-id><pub-id pub-id-type="pmid">16902091</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Jentoft</surname> <given-names>AJ</given-names></name><name><surname>Baeyens</surname> <given-names>JP</given-names></name><name><surname>Bauer</surname> <given-names>JM</given-names></name><name><surname>Boirie</surname> <given-names>Y</given-names></name><name><surname>Cederholm</surname> <given-names>T</given-names></name><name><surname>Landi</surname> <given-names>F</given-names></name><name><surname>Martin</surname> <given-names>FC</given-names></name><name><surname>Michel</surname> <given-names>JP</given-names></name><name><surname>Rolland</surname> <given-names>Y</given-names></name><name><surname>Schneider</surname> <given-names>SM</given-names></name><name><surname>Topinková</surname> <given-names>E</given-names></name><name><surname>Vandewoude</surname> <given-names>M</given-names></name><name><surname>Zamboni</surname> <given-names>M</given-names></name><collab>European Working Group on Sarcopenia in Older People</collab></person-group><year iso-8601-date="2010">2010</year><article-title>Sarcopenia: european consensus on definition and diagnosis: report of the european working group on Sarcopenia in older people</article-title><source>Age and Ageing</source><volume>39</volume><fpage>412</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1093/ageing/afq034</pub-id><pub-id pub-id-type="pmid">20392703</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demontis</surname> <given-names>F</given-names></name><name><surname>Piccirillo</surname> <given-names>R</given-names></name><name><surname>Goldberg</surname> <given-names>AL</given-names></name><name><surname>Perrimon</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mechanisms of skeletal muscle aging: insights from Drosophila and mammalian models</article-title><source>Disease Models &amp; Mechanisms</source><volume>6</volume><fpage>1339</fpage><lpage>1352</lpage><pub-id pub-id-type="doi">10.1242/dmm.012559</pub-id><pub-id pub-id-type="pmid">24092876</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Distefano</surname> <given-names>G</given-names></name><name><surname>Goodpaster</surname> <given-names>BH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Effects of exercise and aging on skeletal muscle</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>8</volume><elocation-id>a029785</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a029785</pub-id><pub-id pub-id-type="pmid">28432116</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowling</surname> <given-names>JJ</given-names></name><name><surname>Moore</surname> <given-names>SA</given-names></name><name><surname>Kalimo</surname> <given-names>H</given-names></name><name><surname>Minassian</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>X-linked myopathy with excessive autophagy: a failure of self-eating</article-title><source>Acta Neuropathologica</source><volume>129</volume><fpage>383</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1007/s00401-015-1393-4</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Souza</surname> <given-names>RF</given-names></name><name><surname>Woodhead</surname> <given-names>JST</given-names></name><name><surname>Zeng</surname> <given-names>N</given-names></name><name><surname>Blenkiron</surname> <given-names>C</given-names></name><name><surname>Merry</surname> <given-names>TL</given-names></name><name><surname>Cameron-Smith</surname> <given-names>D</given-names></name><name><surname>Mitchell</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Circulatory exosomal miRNA following intense exercise is unrelated to muscle and plasma miRNA abundances</article-title><source>American Journal of Physiology-Endocrinology and Metabolism</source><volume>315</volume><fpage>E723</fpage><lpage>E733</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00138.2018</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ejlerskov</surname> <given-names>P</given-names></name><name><surname>Rubinsztein</surname> <given-names>DC</given-names></name><name><surname>Pocock</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>IFNB/interferon-β regulates autophagy via a <italic>MIR1</italic>-TBC1D15-RAB7 pathway</article-title><source>Autophagy</source><volume>16</volume><fpage>767</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1718384</pub-id><pub-id pub-id-type="pmid">31958036</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerisch</surname> <given-names>B</given-names></name><name><surname>Rottiers</surname> <given-names>V</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Motola</surname> <given-names>DL</given-names></name><name><surname>Cummins</surname> <given-names>CL</given-names></name><name><surname>Lehrach</surname> <given-names>H</given-names></name><name><surname>Mangelsdorf</surname> <given-names>DJ</given-names></name><name><surname>Antebi</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A bile acid-like steroid modulates <italic>Caenorhabditis elegans</italic> lifespan through nuclear receptor signaling</article-title><source>PNAS</source><volume>104</volume><fpage>5014</fpage><lpage>5019</lpage><pub-id pub-id-type="doi">10.1073/pnas.0700847104</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosswendt</surname> <given-names>S</given-names></name><name><surname>Filipchyk</surname> <given-names>A</given-names></name><name><surname>Manzano</surname> <given-names>M</given-names></name><name><surname>Klironomos</surname> <given-names>F</given-names></name><name><surname>Schilling</surname> <given-names>M</given-names></name><name><surname>Herzog</surname> <given-names>M</given-names></name><name><surname>Gottwein</surname> <given-names>E</given-names></name><name><surname>Rajewsky</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Unambiguous identification of miRNA:target site interactions by different types of ligation reactions</article-title><source>Molecular Cell</source><volume>54</volume><fpage>1042</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.03.049</pub-id><pub-id pub-id-type="pmid">24857550</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>S</given-names></name><name><surname>Kay</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>How do miRNAs mediate translational repression?</article-title><source>Silence</source><volume>1</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1186/1758-907X-1-11</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>Z</given-names></name><name><surname>Maki</surname> <given-names>M</given-names></name><name><surname>Ding</surname> <given-names>R</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>zhang</surname> <given-names>B</given-names></name><name><surname>Xiong</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues</article-title><source>Scientific Reports</source><volume>4</volume><elocation-id>5150</elocation-id><pub-id pub-id-type="doi">10.1038/srep05150</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermann</surname> <given-names>GJ</given-names></name><name><surname>Schroeder</surname> <given-names>LK</given-names></name><name><surname>Hieb</surname> <given-names>CA</given-names></name><name><surname>Kershner</surname> <given-names>AM</given-names></name><name><surname>Rabbitts</surname> <given-names>BM</given-names></name><name><surname>Fonarev</surname> <given-names>P</given-names></name><name><surname>Grant</surname> <given-names>BD</given-names></name><name><surname>Priess</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Genetic analysis of lysosomal trafficking in <italic>Caenorhabditis elegans</italic></article-title><source>Molecular Biology of the Cell</source><volume>16</volume><fpage>3273</fpage><lpage>3288</lpage><pub-id pub-id-type="doi">10.1091/mbc.e05-01-0060</pub-id><pub-id pub-id-type="pmid">15843430</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herndon</surname> <given-names>LA</given-names></name><name><surname>Schmeissner</surname> <given-names>PJ</given-names></name><name><surname>Dudaronek</surname> <given-names>JM</given-names></name><name><surname>Brown</surname> <given-names>PA</given-names></name><name><surname>Listner</surname> <given-names>KM</given-names></name><name><surname>Sakano</surname> <given-names>Y</given-names></name><name><surname>Paupard</surname> <given-names>MC</given-names></name><name><surname>Hall</surname> <given-names>DH</given-names></name><name><surname>Driscoll</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Stochastic and genetic factors influence tissue-specific decline in ageing <italic>C. elegans</italic></article-title><source>Nature</source><volume>419</volume><fpage>808</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.1038/nature01135</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname> <given-names>L</given-names></name><name><surname>Zhu</surname> <given-names>G</given-names></name><name><surname>Wei</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung Cancer cells by inhibiting autophagy related 3-mediated autophagy</article-title><source>Cell Biology International</source><volume>42</volume><fpage>1240</fpage><lpage>1249</lpage><pub-id pub-id-type="doi">10.1002/cbin.10995</pub-id><pub-id pub-id-type="pmid">29851226</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibáñez-Ventoso</surname> <given-names>C</given-names></name><name><surname>Herrera</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>E</given-names></name><name><surname>Motto</surname> <given-names>D</given-names></name><name><surname>Driscoll</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Automated analysis of <italic>C. elegans</italic> swim behavior using CeleST software</article-title><source>Journal of Visualized Experiments</source><volume>118</volume><elocation-id>54359</elocation-id><pub-id pub-id-type="doi">10.3791/54359</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivey</surname> <given-names>KN</given-names></name><name><surname>Muth</surname> <given-names>A</given-names></name><name><surname>Arnold</surname> <given-names>J</given-names></name><name><surname>King</surname> <given-names>FW</given-names></name><name><surname>Yeh</surname> <given-names>RF</given-names></name><name><surname>Fish</surname> <given-names>JE</given-names></name><name><surname>Hsiao</surname> <given-names>EC</given-names></name><name><surname>Schwartz</surname> <given-names>RJ</given-names></name><name><surname>Conklin</surname> <given-names>BR</given-names></name><name><surname>Bernstein</surname> <given-names>HS</given-names></name><name><surname>Srivastava</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>MicroRNA regulation of cell lineages in mouse and human embryonic stem cells</article-title><source>Cell Stem Cell</source><volume>2</volume><fpage>219</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2008.01.016</pub-id><pub-id pub-id-type="pmid">18371447</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivey</surname> <given-names>KN</given-names></name><name><surname>Srivastava</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>microRNAs as developmental regulators</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>7</volume><elocation-id>a008144</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a008144</pub-id><pub-id pub-id-type="pmid">26134312</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jan</surname> <given-names>CH</given-names></name><name><surname>Friedman</surname> <given-names>RC</given-names></name><name><surname>Ruby</surname> <given-names>JG</given-names></name><name><surname>Bartel</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Formation, regulation and evolution of <italic>Caenorhabditis elegans</italic> 3′UTRs</article-title><source>Nature</source><volume>469</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1038/nature09616</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamath</surname> <given-names>R</given-names></name><name><surname>Ahringer</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Genome-wide RNAi screening in <italic>Caenorhabditis elegans</italic></article-title><source>Methods</source><volume>30</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/S1046-2023(03)00050-1</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lall</surname> <given-names>S</given-names></name><name><surname>Grün</surname> <given-names>D</given-names></name><name><surname>Krek</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Wang</surname> <given-names>YL</given-names></name><name><surname>Dewey</surname> <given-names>CN</given-names></name><name><surname>Sood</surname> <given-names>P</given-names></name><name><surname>Colombo</surname> <given-names>T</given-names></name><name><surname>Bray</surname> <given-names>N</given-names></name><name><surname>Macmenamin</surname> <given-names>P</given-names></name><name><surname>Kao</surname> <given-names>HL</given-names></name><name><surname>Gunsalus</surname> <given-names>KC</given-names></name><name><surname>Pachter</surname> <given-names>L</given-names></name><name><surname>Piano</surname> <given-names>F</given-names></name><name><surname>Rajewsky</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A genome-wide map of conserved microRNA targets in <italic>C. elegans</italic></article-title><source>Current Biology</source><volume>16</volume><fpage>460</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2006.01.050</pub-id><pub-id pub-id-type="pmid">16458514</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liégeois</surname> <given-names>S</given-names></name><name><surname>Benedetto</surname> <given-names>A</given-names></name><name><surname>Garnier</surname> <given-names>J-M</given-names></name><name><surname>Schwab</surname> <given-names>Y</given-names></name><name><surname>Labouesse</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The V0-ATPase mediates apical secretion of exosomes containing Hedgehog-related proteins in <italic>Caenorhabditis elegans</italic></article-title><source>Journal of Cell Biology</source><volume>173</volume><fpage>949</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1083/jcb.200511072</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>X-X</given-names></name><name><surname>Sen</surname> <given-names>I</given-names></name><name><surname>Janssens</surname> <given-names>GE</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Fonslow</surname> <given-names>BR</given-names></name><name><surname>Edgar</surname> <given-names>D</given-names></name><name><surname>Stroustrup</surname> <given-names>N</given-names></name><name><surname>Swoboda</surname> <given-names>P</given-names></name><name><surname>Yates</surname> <given-names>JR</given-names></name><name><surname>Ruvkun</surname> <given-names>G</given-names></name><name><surname>Riedel</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>DAF-16/FOXO and HLH-30/TFEB function as combinatorial transcription factors to promote stress resistance and longevity</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4400</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06624-0</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>N</given-names></name><name><surname>Bezprozvannaya</surname> <given-names>S</given-names></name><name><surname>Shelton</surname> <given-names>JM</given-names></name><name><surname>Frisard</surname> <given-names>MI</given-names></name><name><surname>Hulver</surname> <given-names>MW</given-names></name><name><surname>McMillan</surname> <given-names>RP</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Voelker</surname> <given-names>KA</given-names></name><name><surname>Grange</surname> <given-names>RW</given-names></name><name><surname>Richardson</surname> <given-names>JA</given-names></name><name><surname>Bassel-Duby</surname> <given-names>R</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy</article-title><source>Journal of Clinical Investigation</source><volume>121</volume><fpage>3258</fpage><lpage>3268</lpage><pub-id pub-id-type="doi">10.1172/JCI46267</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname> <given-names>VG</given-names></name><name><surname>Javadi</surname> <given-names>CS</given-names></name><name><surname>Ngo</surname> <given-names>E</given-names></name><name><surname>Ngo</surname> <given-names>L</given-names></name><name><surname>Lagow</surname> <given-names>RD</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Age-related changes in climbing behavior and neural circuit physiology in <italic>Drosophila</italic></article-title><source>Developmental Neurobiology</source><volume>67</volume><fpage>778</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1002/dneu.20388</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname> <given-names>NJ</given-names></name><name><surname>Ow</surname> <given-names>MC</given-names></name><name><surname>Reece-Hoyes</surname> <given-names>JS</given-names></name><name><surname>Barrasa</surname> <given-names>MI</given-names></name><name><surname>Ambros</surname> <given-names>VR</given-names></name><name><surname>Walhout</surname> <given-names>AJM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Genome-scale spatiotemporal analysis of <italic>Caenorhabditis elegans</italic> microRNA promoter activity</article-title><source>Genome Research</source><volume>18</volume><fpage>2005</fpage><lpage>2015</lpage><pub-id pub-id-type="doi">10.1101/gr.083055.108</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>MS</given-names></name><name><surname>Lekkas</surname> <given-names>P</given-names></name><name><surname>Braddock</surname> <given-names>JM</given-names></name><name><surname>Farman</surname> <given-names>GP</given-names></name><name><surname>Ballif</surname> <given-names>BA</given-names></name><name><surname>Irving</surname> <given-names>TC</given-names></name><name><surname>Maughan</surname> <given-names>DW</given-names></name><name><surname>Vigoreaux</surname> <given-names>JO</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Aging enhances indirect flight muscle fiber performance yet decreases flight ability in <italic>Drosophila</italic></article-title><source>Biophysical Journal</source><volume>95</volume><fpage>2391</fpage><lpage>2401</lpage><pub-id pub-id-type="doi">10.1529/biophysj.108.130005</pub-id><pub-id pub-id-type="pmid">18515368</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miska</surname> <given-names>EA</given-names></name><name><surname>Alvarez-Saavedra</surname> <given-names>E</given-names></name><name><surname>Abbott</surname> <given-names>AL</given-names></name><name><surname>Lau</surname> <given-names>NC</given-names></name><name><surname>Hellman</surname> <given-names>AB</given-names></name><name><surname>McGonagle</surname> <given-names>SM</given-names></name><name><surname>Bartel</surname> <given-names>DP</given-names></name><name><surname>Ambros</surname> <given-names>VR</given-names></name><name><surname>Horvitz</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Most <italic>Caenorhabditis elegans</italic> microRNAs are individually not essential for development or viability</article-title><source>PLOS Genetics</source><volume>3</volume><elocation-id>e215</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.0030215</pub-id><pub-id pub-id-type="pmid">18085825</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchelson</surname> <given-names>KR</given-names></name><name><surname>Qin</surname> <given-names>WY</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease</article-title><source>World Journal of Biological Chemistry</source><volume>6</volume><fpage>162</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.4331/wjbc.v6.i3.162</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morley</surname> <given-names>JF</given-names></name><name><surname>Brignull</surname> <given-names>HR</given-names></name><name><surname>Weyers</surname> <given-names>JJ</given-names></name><name><surname>Morimoto</surname> <given-names>RI</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in <italic>Caenorhabditis elegans</italic></article-title><source>PNAS</source><volume>99</volume><fpage>10417</fpage><lpage>10422</lpage><pub-id pub-id-type="doi">10.1073/pnas.152161099</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Aging muscle</article-title><source>The American Journal of Clinical Nutrition</source><volume>81</volume><fpage>953</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1093/ajcn/81.5.953</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nehammer</surname> <given-names>C</given-names></name><name><surname>Ejlerskov</surname> <given-names>P</given-names></name><name><surname>Gopal</surname> <given-names>S</given-names></name><name><surname>Handley</surname> <given-names>A</given-names></name><name><surname>Ng</surname> <given-names>L</given-names></name><name><surname>Moreira</surname> <given-names>P</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Issazadeh-Navikas</surname> <given-names>S</given-names></name><name><surname>Rubinsztein</surname> <given-names>DC</given-names></name><name><surname>Pocock</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Interferon-β-induced miR-1 alleviates toxic protein accumulation by controlling autophagy</article-title><source>eLife</source><volume>8</volume><elocation-id>e49930</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.49930</pub-id><pub-id pub-id-type="pmid">31799933</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Rourke</surname> <given-names>EJ</given-names></name><name><surname>Ruvkun</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MXL-3 and HLH-30 transcriptionally link lipolysis and autophagy to nutrient availability</article-title><source>Nature Cell Biology</source><volume>15</volume><fpage>668</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1038/ncb2741</pub-id><pub-id pub-id-type="pmid">23604316</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panwar</surname> <given-names>B</given-names></name><name><surname>Omenn</surname> <given-names>GS</given-names></name><name><surname>Guan</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>miRmine: a database of human miRNA expression profiles</article-title><source>Bioinformatics</source><volume>33</volume><fpage>1554</fpage><lpage>1560</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btx019</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Riverol</surname> <given-names>Y</given-names></name><name><surname>Csordas</surname> <given-names>A</given-names></name><name><surname>Bai</surname> <given-names>J</given-names></name><name><surname>Bernal-Llinares</surname> <given-names>M</given-names></name><name><surname>Hewapathirana</surname> <given-names>S</given-names></name><name><surname>Kundu</surname> <given-names>DJ</given-names></name><name><surname>Inuganti</surname> <given-names>A</given-names></name><name><surname>Griss</surname> <given-names>J</given-names></name><name><surname>Mayer</surname> <given-names>G</given-names></name><name><surname>Eisenacher</surname> <given-names>M</given-names></name><name><surname>Pérez</surname> <given-names>E</given-names></name><name><surname>Uszkoreit</surname> <given-names>J</given-names></name><name><surname>Pfeuffer</surname> <given-names>J</given-names></name><name><surname>Sachsenberg</surname> <given-names>T</given-names></name><name><surname>Yilmaz</surname> <given-names>S</given-names></name><name><surname>Tiwary</surname> <given-names>S</given-names></name><name><surname>Cox</surname> <given-names>J</given-names></name><name><surname>Audain</surname> <given-names>E</given-names></name><name><surname>Walzer</surname> <given-names>M</given-names></name><name><surname>Jarnuczak</surname> <given-names>AF</given-names></name><name><surname>Ternent</surname> <given-names>T</given-names></name><name><surname>Brazma</surname> <given-names>A</given-names></name><name><surname>Vizcaíno</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The PRIDE database and related tools and resources in 2019: improving support for quantification data</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D442</fpage><lpage>D450</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1106</pub-id><pub-id pub-id-type="pmid">30395289</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollock</surname> <given-names>RD</given-names></name><name><surname>O'Brien</surname> <given-names>KA</given-names></name><name><surname>Daniels</surname> <given-names>LJ</given-names></name><name><surname>Nielsen</surname> <given-names>KB</given-names></name><name><surname>Rowlerson</surname> <given-names>A</given-names></name><name><surname>Duggal</surname> <given-names>NA</given-names></name><name><surname>Lazarus</surname> <given-names>NR</given-names></name><name><surname>Lord</surname> <given-names>JM</given-names></name><name><surname>Philp</surname> <given-names>A</given-names></name><name><surname>Harridge</surname> <given-names>SDR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Properties of the vastus lateralis muscle in relation to age and physiological function in master cyclists aged 55-79 years</article-title><source>Aging Cell</source><volume>17</volume><elocation-id>e12735</elocation-id><pub-id pub-id-type="doi">10.1111/acel.12735</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Restif</surname> <given-names>C</given-names></name><name><surname>Ibáñez-Ventoso</surname> <given-names>C</given-names></name><name><surname>Vora</surname> <given-names>MM</given-names></name><name><surname>Guo</surname> <given-names>S</given-names></name><name><surname>Metaxas</surname> <given-names>D</given-names></name><name><surname>Driscoll</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CeleST: computer vision software for quantitative analysis of <italic>C. elegans</italic> swim behavior reveals novel features of locomotion</article-title><source>PLOS Computational Biology</source><volume>10</volume><elocation-id>e1003702</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003702</pub-id><pub-id pub-id-type="pmid">25033081</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rual</surname> <given-names>JF</given-names></name><name><surname>Ceron</surname> <given-names>J</given-names></name><name><surname>Koreth</surname> <given-names>J</given-names></name><name><surname>Hao</surname> <given-names>T</given-names></name><name><surname>Nicot</surname> <given-names>AS</given-names></name><name><surname>Hirozane-Kishikawa</surname> <given-names>T</given-names></name><name><surname>Vandenhaute</surname> <given-names>J</given-names></name><name><surname>Orkin</surname> <given-names>SH</given-names></name><name><surname>Hill</surname> <given-names>DE</given-names></name><name><surname>van den Heuvel</surname> <given-names>S</given-names></name><name><surname>Vidal</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Toward improving <italic>Caenorhabditis elegans</italic> phenome mapping with an ORFeome-based RNAi library</article-title><source>Genome Research</source><volume>14</volume><fpage>2162</fpage><lpage>2168</lpage><pub-id pub-id-type="doi">10.1101/gr.2505604</pub-id><pub-id pub-id-type="pmid">15489339</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sardiello</surname> <given-names>M</given-names></name><name><surname>Palmieri</surname> <given-names>M</given-names></name><name><surname>di Ronza</surname> <given-names>A</given-names></name><name><surname>Medina</surname> <given-names>DL</given-names></name><name><surname>Valenza</surname> <given-names>M</given-names></name><name><surname>Gennarino</surname> <given-names>VA</given-names></name><name><surname>Di Malta</surname> <given-names>C</given-names></name><name><surname>Donaudy</surname> <given-names>F</given-names></name><name><surname>Embrione</surname> <given-names>V</given-names></name><name><surname>Polishchuk</surname> <given-names>RS</given-names></name><name><surname>Banfi</surname> <given-names>S</given-names></name><name><surname>Parenti</surname> <given-names>G</given-names></name><name><surname>Cattaneo</surname> <given-names>E</given-names></name><name><surname>Ballabio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A gene network regulating lysosomal biogenesis and function</article-title><source>Science</source><volume>325</volume><fpage>473</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1126/science.1174447</pub-id><pub-id pub-id-type="pmid">19556463</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settembre</surname> <given-names>C</given-names></name><name><surname>Di Malta</surname> <given-names>C</given-names></name><name><surname>Polito</surname> <given-names>VA</given-names></name><name><surname>Garcia Arencibia</surname> <given-names>M</given-names></name><name><surname>Vetrini</surname> <given-names>F</given-names></name><name><surname>Erdin</surname> <given-names>S</given-names></name><name><surname>Erdin</surname> <given-names>SU</given-names></name><name><surname>Huynh</surname> <given-names>T</given-names></name><name><surname>Medina</surname> <given-names>D</given-names></name><name><surname>Colella</surname> <given-names>P</given-names></name><name><surname>Sardiello</surname> <given-names>M</given-names></name><name><surname>Rubinsztein</surname> <given-names>DC</given-names></name><name><surname>Ballabio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>TFEB links autophagy to lysosomal biogenesis</article-title><source>Science</source><volume>332</volume><fpage>1429</fpage><lpage>1433</lpage><pub-id pub-id-type="doi">10.1126/science.1204592</pub-id><pub-id pub-id-type="pmid">21617040</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settembre</surname> <given-names>C</given-names></name><name><surname>Fraldi</surname> <given-names>A</given-names></name><name><surname>Medina</surname> <given-names>DL</given-names></name><name><surname>Ballabio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Signals from the lysosome: a control centre for cellular clearance and energy metabolism</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>14</volume><fpage>283</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1038/nrm3565</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname> <given-names>DJ</given-names></name><name><surname>Madison</surname> <given-names>JM</given-names></name><name><surname>Conery</surname> <given-names>AL</given-names></name><name><surname>Thompson-Peer</surname> <given-names>KL</given-names></name><name><surname>Soskis</surname> <given-names>M</given-names></name><name><surname>Ruvkun</surname> <given-names>GB</given-names></name><name><surname>Kaplan</surname> <given-names>JM</given-names></name><name><surname>Kim</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions</article-title><source>Cell</source><volume>133</volume><fpage>903</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.04.035</pub-id><pub-id pub-id-type="pmid">18510933</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snel</surname> <given-names>B</given-names></name><name><surname>Lehmann</surname> <given-names>G</given-names></name><name><surname>Bork</surname> <given-names>P</given-names></name><name><surname>Huynen</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene</article-title><source>Nucleic Acids Research</source><volume>28</volume><fpage>3442</fpage><lpage>3444</lpage><pub-id pub-id-type="doi">10.1093/nar/28.18.3442</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname> <given-names>A</given-names></name><name><surname>Brennecke</surname> <given-names>J</given-names></name><name><surname>Bushati</surname> <given-names>N</given-names></name><name><surname>Russell</surname> <given-names>RB</given-names></name><name><surname>Cohen</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution</article-title><source>Cell</source><volume>123</volume><fpage>1133</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.11.023</pub-id><pub-id pub-id-type="pmid">16337999</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tharyan</surname> <given-names>RG</given-names></name><name><surname>Annibal</surname> <given-names>A</given-names></name><name><surname>Schiffer</surname> <given-names>I</given-names></name><name><surname>Laboy</surname> <given-names>R</given-names></name><name><surname>Atanassov</surname> <given-names>I</given-names></name><name><surname>Weber</surname> <given-names>AL</given-names></name><name><surname>Gerisch</surname> <given-names>B</given-names></name><name><surname>Antebi</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>NFYB-1 regulates mitochondrial function and longevity via lysosomal prosaposin</article-title><source>Nature Metabolism</source><volume>2</volume><fpage>387</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1038/s42255-020-0200-2</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Wong</surname> <given-names>L-Y</given-names></name><name><surname>Neumann</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Sun</surname> <given-names>A</given-names></name><name><surname>Antoons</surname> <given-names>G</given-names></name><name><surname>Strzelecka</surname> <given-names>A</given-names></name><name><surname>Glatz</surname> <given-names>JFC</given-names></name><name><surname>Nabben</surname> <given-names>M</given-names></name><name><surname>Luiken</surname> <given-names>JJFP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Augmenting vacuolar H+-ATPase function prevents cardiomyocytes from Lipid-Overload induced dysfunction</article-title><source>International Journal of Molecular Sciences</source><volume>21</volume><elocation-id>1520</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21041520</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname> <given-names>JA</given-names></name><name><surname>Baxter</surname> <given-names>DH</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Huang</surname> <given-names>DY</given-names></name><name><surname>Huang</surname> <given-names>KH</given-names></name><name><surname>Lee</surname> <given-names>MJ</given-names></name><name><surname>Galas</surname> <given-names>DJ</given-names></name><name><surname>Wang</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The microRNA spectrum in 12 body fluids</article-title><source>Clinical Chemistry</source><volume>56</volume><fpage>1733</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.1373/clinchem.2010.147405</pub-id><pub-id pub-id-type="pmid">20847327</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>Y</given-names></name><name><surname>Peng</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Sachidanandam</surname> <given-names>R</given-names></name><name><surname>Tu</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Falce</surname> <given-names>C</given-names></name><name><surname>Sobie</surname> <given-names>EA</given-names></name><name><surname>Lebeche</surname> <given-names>D</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Multifaceted roles of miR-1s in repressing the fetal gene program in the heart</article-title><source>Cell Research</source><volume>24</volume><fpage>278</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1038/cr.2014.12</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wüst</surname> <given-names>S</given-names></name><name><surname>Dröse</surname> <given-names>S</given-names></name><name><surname>Heidler</surname> <given-names>J</given-names></name><name><surname>Wittig</surname> <given-names>I</given-names></name><name><surname>Klockner</surname> <given-names>I</given-names></name><name><surname>Franko</surname> <given-names>A</given-names></name><name><surname>Bonke</surname> <given-names>E</given-names></name><name><surname>Günther</surname> <given-names>S</given-names></name><name><surname>Gärtner</surname> <given-names>U</given-names></name><name><surname>Boettger</surname> <given-names>T</given-names></name><name><surname>Braun</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Metabolic maturation during muscle stem cell differentiation is achieved by miR-1/133a-Mediated inhibition of the Dlk1-Dio3 mega gene cluster</article-title><source>Cell Metabolism</source><volume>27</volume><fpage>1026</fpage><lpage>1039</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.02.022</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Cao</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Yue</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>MicroRNA‐1 facilitates hypoxia‐induced injury by targeting NOTCH3</article-title><source>Journal of Cellular Biochemistry</source><volume>121</volume><fpage>4458</fpage><lpage>4469</lpage><pub-id pub-id-type="doi">10.1002/jcb.29663</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>CS</given-names></name><name><surname>Jiang</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Zhu</surname> <given-names>M</given-names></name><name><surname>Peng</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>YL</given-names></name><name><surname>Wu</surname> <given-names>YQ</given-names></name><name><surname>Li</surname> <given-names>TY</given-names></name><name><surname>Liang</surname> <given-names>Y</given-names></name><name><surname>Lu</surname> <given-names>Z</given-names></name><name><surname>Lian</surname> <given-names>G</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Guo</surname> <given-names>H</given-names></name><name><surname>Yin</surname> <given-names>Z</given-names></name><name><surname>Ye</surname> <given-names>Z</given-names></name><name><surname>Han</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>JW</given-names></name><name><surname>Yin</surname> <given-names>H</given-names></name><name><surname>Lin</surname> <given-names>SY</given-names></name><name><surname>Lin</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism</article-title><source>Cell Metabolism</source><volume>20</volume><fpage>526</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.06.014</pub-id><pub-id pub-id-type="pmid">25002183</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Ransom</surname> <given-names>JF</given-names></name><name><surname>Li</surname> <given-names>A</given-names></name><name><surname>Vedantham</surname> <given-names>V</given-names></name><name><surname>von Drehle</surname> <given-names>M</given-names></name><name><surname>Muth</surname> <given-names>AN</given-names></name><name><surname>Tsuchihashi</surname> <given-names>T</given-names></name><name><surname>McManus</surname> <given-names>MT</given-names></name><name><surname>Schwartz</surname> <given-names>RJ</given-names></name><name><surname>Srivastava</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2</article-title><source>Cell</source><volume>129</volume><fpage>303</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.03.030</pub-id><pub-id pub-id-type="pmid">17397913</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Song</surname> <given-names>M</given-names></name><name><surname>He</surname> <given-names>Z</given-names></name><name><surname>Cui</surname> <given-names>G</given-names></name><name><surname>Peng</surname> <given-names>G</given-names></name><name><surname>Dieterich</surname> <given-names>C</given-names></name><name><surname>Antebi</surname> <given-names>A</given-names></name><name><surname>Jing</surname> <given-names>N</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A secreted microRNA disrupts autophagy in distinct tissues of <italic>Caenorhabditis elegans</italic> upon ageing</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4827</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-12821-2</pub-id><pub-id pub-id-type="pmid">31645592</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.66768.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Leiser</surname><given-names>Scott F</given-names></name><role>Reviewing Editor</role><aff><institution>University of Michigan</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Lee</surname><given-names>Seung-Jae V</given-names></name><role>Reviewer</role><aff><institution>Korea Advanced Institute of Science and Technology</institution><country>Republic of Korea</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper elegantly demonstrates how the loss of a single micro-RNA contributes to maintaining muscle function during aging under stressful conditions. Through this principal finding and their additional mechanistic results, this work suggests that the role of small non-coding micro-RNA molecules is more complex than previously understood, and will be the subject of additional future studies.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;miR-1 coordinately regulates lysosomal v-ATPase and biogenesis to impact proteotoxicity and muscle function during aging&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by Scott Leiser as Reviewing Editor and Matt Kaeberlein as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Seung-Jae V Lee (Reviewer #1).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Summary of review and essential revisions:</p><p>Summary of manuscript: In this manuscript entitled &quot;miR-1 coordinately regulates lysosomal v-ATPase and biogenesis to impact proteotoxicity and muscle function during aging&quot;, the authors demonstrated that mir-1 loss of function mutations contributes to maintaining muscle functions during aging under proteotoxic conditions in the nematode <italic>C. elegans</italic>. They found that deletion of mir-1 improved muscle functions in <italic>C. elegans</italic> that expressed polyQ, a model of Huntington's disease. Using bioinformatic and proteomic analyses, the authors identified vacuolar ATPase subunits as targets of miR-1. They then focused their work on vha-13, which encodes ATP6VIA subunit of the vacuolar ATPase, and demonstrated that miR-1 directly bound the 3' UTR of vha-13 for downregulation, which contributes to ameliorating proteotoxicity and delaying muscle aging. They also showed that miR-1 regulates lysosomal biogenesis and acidification through HLH-30/TFEB. The topic and content of this paper is novel and important, because this is the first paper demonstrating important roles of evolutionarily conserved miR-1 in muscle aging and proteostasis.</p><p>Summary of discussion: The reviewers and I are in agreement that the data of the manuscript are of extremely high quality with molecular genetics, cell biology, bioinformatics and proteomic analysis. We believe this is a worthwhile manuscript for publication in <italic>eLife</italic>, but should be revised with some additional data. Of highest importance, we all agree that using at least one other aggregation model (probably Q40, although others would be interesting as well) is needed, seeing as though your data disagree with a previous publication and you have the ability to test the robustness of the phenotype in multiple aggregation models. Besides this, there are a number of issues brought up during review that should be addressed in a revised manuscript, but that we believe can be addressed within the text.</p><p>1) I think the authors' efforts to identify phenotypes caused by mir-1 mutations are rigorous and comprehensive. Nevertheless, I believe it will be even better if they test one or more proteotoxic stress conditions to determine whether miR-1 mutant phenotype is specific to Q35 or general for some other proteotoxic stress conditions. For example, they can combine mir-1 mutation with other established muscle proteotoxicity models such as amyloid β or sod1 transgene in muscles. Alternatively, I wonder whether miR-1 mutations suppress phenotypes caused by hsf-1 RNAi or by ts mutations that Morimoto group used (Gidalevitz et al., 2006, Science), which may act as sensitized conditions for detecting mir-1 mutant phenotypes.</p><p>1b) It is greatly appreciated that the authors bring up the conflicting findings with the Q40 reporter versus their Q35 study. The authors should, at the very least, test the most robust assay in their arsenal with the Q40 strain. It is very possible that five</p><p>extra repeats could be causal so this would be interesting.</p><p>2) The data in the current Figure 4 are very interesting but are not as strong as the current Figure 3. Therefore, the current structure of the paper makes readers feel the paper is rather incomplete. I suggest that the authors consider changing the order of figure 3 and 4 (describing HLH-30 first, and then ATPases and VHA-13), and finishing this paper with stronger data in Figure 3.</p><p>3) The abstract suggests the authors will uncover a role distinct from development, but really the authors manipulate mIR-1 throughout life. This isn't an issue per se as the targets are manipulated post-developmentally. That said, the authors should describe the age-related expression of mIR-1 over the lifespan. Perhaps L4 (end of development), Day 1 early reproduction, Day 5 end of reproduction, and day 12 for midlife? This is important as previous work suggests that miR-1 expression is mostly developmental.</p><p>4) The mutations in putative mIR-1 sites in the vha gene family is nice, but to show sufficiency the authors should add the 3'UTR elements (single or multi) to a non-regulated gene (add to the unc-54 UTR for the GFP reporter in 3F) and show that the sequence can make the target now sensitive to mIR-1 expression.</p><p>5) The short section on HLH-30 is confusing. How is mIR-1 regulating protein localization, but not expression. This could be interesting, but as written it is out of place and detract from the detailed work on vha-13 preceding it.</p><p><italic>Reviewer #1:</italic></p><p>Aging is associated with declines in functions of almost all the tissues and organs, including muscle. miR-1, a small RNA called microRNA, functions in muscles, but the role of miR-1 in aging-associated processes remains unknown. In this paper, the authors convincingly showed that miR-1 plays protective roles in muscle functions during aging and age-associated diseases using the roundworm <italic>Caenorhabditis elegans</italic>. miR-1 is an evolutionarily conserved microRNA that functions in muscles in various species, including mammals. Thus, this study is very valuable for devising strategy for treating muscle aging diseases such as sarcopenia and age-associated diseases caused by proteotoxicity such as Huntington's disease.<italic>Reviewer #2:</italic></p><p>In this study the authors are trying to elucidate a role for the microRNA mIR-1 in aging, which would expand upon its established roles in muscle development. The authors use a combination of powerful molecular and genetic approaches to define new targets of mIR-1that influence muscle health. The authors perform a well designed study and uncover new way to study muscle health with age. The authors conclusions are supported by the data presented and this study defines a new layer of regulation of muscle health over the lifespan, which based on the evolutionary conservation of the players has a high likelihood of informing human health.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.66768.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Summary of review and essential revisions:</p><p>Summary of manuscript: In this manuscript entitled &quot;miR-1 coordinately regulates lysosomal v-ATPase and biogenesis to impact proteotoxicity and muscle function during aging&quot;, the authors demonstrated that mir-1 loss of function mutations contributes to maintaining muscle functions during aging under proteotoxic conditions in the nematode <italic>C. elegans</italic>. They found that deletion of mir-1 improved muscle functions in <italic>C. elegans</italic> that expressed polyQ, a model of Huntington's disease. Using bioinformatic and proteomic analyses, the authors identified vacuolar ATPase subunits as targets of miR-1. They then focused their work on vha-13, which encodes ATP6VIA subunit of the vacuolar ATPase, and demonstrated that miR-1 directly bound the 3' UTR of vha-13 for downregulation, which contributes to ameliorating proteotoxicity and delaying muscle aging. They also showed that miR-1 regulates lysosomal biogenesis and acidification through HLH-30/TFEB. The topic and content of this paper is novel and important, because this is the first paper demonstrating important roles of evolutionarily conserved miR-1 in muscle aging and proteostasis.</p><p>Summary of discussion: The reviewers and I are in agreement that the data of the manuscript are of extremely high quality with molecular genetics, cell biology, bioinformatics and proteomic analysis. We believe this is a worthwhile manuscript for publication in eLife, but should be revised with some additional data. Of highest importance, we all agree that using at least one other aggregation model (probably Q40, although others would be interesting as well) is needed, seeing as though your data disagree with a previous publication and you have the ability to test the robustness of the phenotype in multiple aggregation models. Besides this, there are a number of issues brought up during review that should be addressed in a revised manuscript, but that we believe can be addressed within the text.</p></disp-quote><p>Thank you for this excellent suggestion. We measured protein aggregation and motility in polyQ40 and α-synuclein proteotoxicity models. We added the following text in the results:</p><p>“To determine whether <italic>mir-1</italic> loss generally protects against proteotoxic stress, we</p><p>examined two other muscle-specific proteotoxic models: polyQ40 and human α-synuclein (α-syn). In contrast to polyQ35, which forms aggregates during adulthood, polyQ40 aggregates were already visible during development. We found aggregate numbers significantly reduced in <italic>mir-1(gk276)</italic>;Q40 L4 worms (Supplemental Table 2). However, the motility of <italic>mir-1(gk276)</italic>;Q40 worms, determined by 1 minute thrashing assays, was unaffected at day 3 of adulthood and reduced in 2 out of 3 experiments at day 7 of adulthood compared to Q40 controls (Supplemental Table 2). Similarly aggregate numbers were reduced in <italic>mir-1(gk276)</italic>;α-syn worms at day 1 of adulthood compared to the α-syn control (Supplemental Table 2). Thrashing of <italic>mir-1(gk276)</italic>;α-syn worms was significantly reduced on day 1 of adulthood, but by day 5 there was no significant difference in motility between <italic>mir-1(gk276)</italic>;α-syn and α-syn worms (Supplemental Figure 1O, Supplemental Table 2). Taken together, <italic>mir-1</italic> loss reduced aggregate numbers in 3 different proteotoxic stress paradigms. However, reduced number of aggregates did not always directly correlate with improved motility, reinforcing the notion that protein aggregation may promote or aggravate health depending on the proteotoxic species and age (Cohen, Bieschke, Perciavalle, Kelly, and Dillin, 2006).”</p><p>In the discussion we included the following text:</p><p>“Recently Pocock and colleagues reported that miR-1 downregulates the Rab GTPase TBC-7/TBC1D15, thereby promoting autophagic flux in worms and human cells</p><p>(Nehammer et al., 2019). In <italic>C. elegans</italic> they observed that <italic>mir-1(+)</italic> ameliorates polyQ40</p><p>proteotoxicity, seemingly contradicting our results. We found <italic>mir-1</italic> deletion to reduce</p><p>aggregate numbers in polyQ35, polyQ40 and α-syn models, while effects on motility varied among the three models. The relationship between aggregation and cellular toxicity remains controversial, and the uncoupling of aggregation and toxicity is observed in various disease models. Mammalian studies suggest context-dependent <italic>mir-1</italic> effects, where <italic>mir-1</italic> either promotes or inhibits autophagy (Ejlerskov, Rubinsztein, and Pocock, 2020; Hua, Zhu, and Wei, 2018; Xu, Cao, Zhang, Zhang, and Yue, 2020). Whether miR-1 is proteoprotective or limits proteoprotection in <italic>C. elegans</italic> could hinge on many factors. Because microRNAs generally fine tune regulation, and often work in feedback circuits, their impact on physiology can be subtle, and small differences in culture conditions, genetic background, metabolic state, aggregation onset during development or ageing could give rise to divergent outcomes.”</p><p>We added the data to Supplemental Table 2.</p><disp-quote content-type="editor-comment"><p>1) I think the authors' efforts to identify phenotypes caused by mir-1 mutations are rigorous and comprehensive. Nevertheless, I believe it will be even better if they test one or more proteotoxic stress conditions to determine whether miR-1 mutant phenotype is specific to Q35 or general for some other proteotoxic stress conditions. For example, they can combine mir-1 mutation with other established muscle proteotoxicity models such as amyloid β or sod1 transgene in muscles. Alternatively, I wonder whether miR-1 mutations suppress phenotypes caused by hsf-1 RNAi or by ts mutations that Morimoto group used (Gidalevitz et al., 2006, Science), which may act as sensitized conditions for detecting mir-1 mutant phenotypes.</p></disp-quote><p>We tested the effect of <italic>mir-1(gk276)</italic> as suggested on Q40 and α-synuclein and added</p><p>the data to the paper (see above).</p><disp-quote content-type="editor-comment"><p>1b) It is greatly appreciated that the authors bring up the conflicting findings with the Q40 reporter versus their Q35 study. The authors should, at the very least, test the most robust assay in their arsenal with the Q40 strain. It is very possible that 5 extra repeats could be causal so this would be interesting.</p></disp-quote><p>We tested the effect of <italic>mir-1(gk276)</italic> on Q40 and added the data (see above).</p><disp-quote content-type="editor-comment"><p>2) The data in the current Figure 4 are very interesting but are not as strong as the current Figure 3. Therefore, the current structure of the paper makes readers feel the paper is rather incomplete. I suggest that the authors consider changing the order of figure 3 and 4 (describing HLH-30 first, and then ATPases and VHA-13), and finishing this paper with stronger data in Figure 3.</p></disp-quote><p>Thank you for this suggestion. We rearranged the text to mention the HLH -30 results</p><p>before VHA-13. We now say:</p><p>“We further investigated whether miR-1 regulates these gene products at the</p><p>protein level. We endogenously tagged <italic>vha-5, vha-10, vha-13</italic>, <italic>vha-19</italic> (N-terminus) as</p><p>well as <italic>hlh-30</italic> (C-terminus) by CRISPR/Cas9 using 3xFlag-mNeonGreen-tag. Tagging</p><p><italic>vha-19</italic> and <italic>vha-10</italic> caused lethality and were not pursued further. Tagged <italic>vha-5</italic> showed</p><p>significant upregulation in the pharynx in <italic>mir-1(gk276)</italic> mutants compared to WT, but not in vulva muscle (Supplemental Figure 3A and B, Supplemental Table 7). However, <italic>vha-5</italic> RNAi knockdown had no significant difference in motility compared to controls</p><p>(Figure 2E-G, Supplemental Table S2). Further, we saw no obvious regulation of endogenously tagged <italic>hlh-30</italic> protein levels in the pharynx in late L4 or day 4 adults (Supplemental Figure 4A and B, Supplemental Table 7), though we did see increased nuclear localization in the hypodermis in day 4 <italic>mir-1(gk276)</italic> adults (Figure 4A and 4B).</p><p>N-terminally tagged <italic>vha-13(syb586),</italic> however, was viable, showed expression that</p><p>was regulated, and harboured two potential <italic>mir-1</italic> binding sites in the 3’UTR (Figure 3F,</p><p>Supplemental Figure 3C).”</p><p>Although we changed the text, we nevertheless kept HLH-30::NeonGreen data in Figure</p><p>4, along with lysosome biogenesis data. This is because we feel that swapping Figure 3</p><p>and 4 would interrupt the narrative that goes from <italic>mir-1</italic> target to broader lysosomal</p><p>physiology.</p><disp-quote content-type="editor-comment"><p>3) The abstract suggests the authors will uncover a role distinct from development, but really the authors manipulate mIR-1 throughout life. This isn't an issue per se as the targets are manipulated post-developmentally. That said, the authors should describe the age-related expression of mIR-1 over the lifespan. Perhaps L4 (end of development), Day 1 early reproduction, Day 5 end of reproduction, and day 12 for midlife? This is important as previous work suggests that miR-1 expression is mostly developmental.</p></disp-quote><p>We added data from microRNA-seq analysis of wild-type worms at day 1 of adulthood</p><p>(start of adulthood), day 7 (around the end of the reproductive period), day 14, and day</p><p>21 (around the mean lifespan of wild-type worms) (Yifei Zhou et al., 2019).</p><p>We added the following sentence in the manuscript:</p><p>“While microRNAs are known as important developmental regulators (Ivey and Srivastava, 2015), miR-1 expression also persists throughout adulthood, decliningby half from day 1 to day 14 of adulthood (Supplemental Figure 1A, data from (Zhouet al., 2019).”</p><disp-quote content-type="editor-comment"><p>4) The mutations in putative mIR-1 sites in the vha gene family is nice, but to show sufficiency the authors should add the 3'UTR elements (single or multi) to a non-regulated gene (add to the unc-54 UTR for the GFP reporter in 3F) and show that the sequence can make the target now sensitive to mIR-1 expression.</p></disp-quote><p>The reviewer is correct in pointing out that we did not pursue experiments to show that</p><p>miR-1 binding sites are sufficient for regulation. Our aim for this line of experiments was to show that miR-1 directly regulates <italic>vha-13</italic> expression, and to determine the</p><p>physiologically relevant miR-1 binding sites in the <italic>vha-13</italic> 3’UTR. We successfully</p><p>identified two miR-1 binding sites, which are necessary for miR-1 dependent regulation of <italic>vha-13</italic> expression. In theory, it is possible that introducing these two binding sites into an <italic>unc-54</italic> 3’UTR may confer regulation. However, past examples of microRNA regulation indicate that surrounding sequences of the binding site are also important, as well as secondary structures of the 3’ UTR, and the microRNA binding sites of <italic>lsy-2</italic> or <italic>let-7</italic> are not sufficient (Didiano and Hobert, 2008; Brancanti and Grosshans 2018). These studies actually used the <italic>unc-54</italic> 3’UTR. By inference, miR-1 binding sites would also likely not be sufficient.</p><p>Finally, as an example from our proteomics data, the <italic>unc-44</italic> 3’UTR carries the same two</p><p>miR-1 binding sites as <italic>vha-13</italic> (ACATTCCA and ATTCCA), but does not show the expected derepression in the miR-1 deletion strain. Given these observations, we feel</p><p>that demonstrating sufficiency would be highly unlikely and lies outside of the biologically relevant context and outside of the scope of this paper.</p><disp-quote content-type="editor-comment"><p>5) The short section on HLH-30 is confusing. How is mIR-1 regulating protein localization, but not expression. This could be interesting, but as written it is out of place and detract from the detailed work on vha-13 preceding it.</p></disp-quote><p>We now mention <italic>hlh-30</italic> briefly ahead of the <italic>vha-13</italic> work as in point 2, and say:</p><p>“Further, we saw no obvious regulation of endogenously tagged <italic>hlh-30</italic> protein levels in</p><p>the pharynx in late L4 or day 4 adults (Supplemental Figure 4A and B, Supplemental</p><p>Table 7), though we did see increased nuclear localization in the hypodermis in day 4</p><p><italic>mir-1(gk276)</italic> adults (Figure 4A and 4B).”</p><p>As far as how miR-1 regulates the nuclear localization of HLH-30, we can only speculate</p><p>that it does so by affecting mTOR signaling. We now say in the discussion:</p><p>“Notably, miR-1 predicted targets also include pro-aging components of mTOR signalling such as <italic>let-363/</italic>mTOR and <italic>raga-1/</italic>RagA (targetscan.org), which also regulate</p><p>the activity or localization of these transcription factors.”</p></body></sub-article></article>